TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-3000157	Laminin interactions	1.88963949941539e-05	-10.8765393951421	23	6	0.028436018957346	211	8202	3910,3913,3685,3675,3691,3912	LAMA4,LAMB2,ITGAV,ITGA3,ITGB4,LAMB1
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.000905995163798302	-7.00647658990651	30	5	0.023696682464455	211	8202	182,54492,92737,57534,23220	JAG1,NEURL1B,DNER,MIB1,DTX4
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.00301856624949404	-5.80297331214885	24	4	0.018957345971564	211	8202	10484,6892,3107,64167	SEC23A,TAPBP,HLA-C,ERAP2
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.00421335640396908	-5.46949570332095	42	5	0.023696682464455	211	8202	3910,3913,3685,3691,3912	LAMA4,LAMB2,ITGAV,ITGB4,LAMB1
R-HSA-556833	Metabolism of lipids and lipoproteins	0.00555223482830587	-5.19355476050749	628	27	0.127962085308057	211	8202	1591,10484,8760,5468,3635,27242,84803,7108,10162,79642,9517,51129,1119,123,85441,6307,51,2232,8821,5290,51495,8714,4048,37,204962,6576,3156	CYP24A1,SEC23A,CDS2,PPARG,INPP5D,TNFRSF21,GPAT3,TM7SF2,LPCAT3,ARSJ,SPTLC2,ANGPTL4,CHKA,PLIN2,HELZ2,MSMO1,ACOX1,FDXR,INPP4B,PIK3CA,HACD3,ABCC3,LTA4H,ACADVL,SLC44A5,SLC25A1,HMGCR
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.00607605186501065	-5.10340015823984	15	3	0.014218009478673	211	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.00607605186501065	-5.10340015823984	15	3	0.014218009478673	211	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.00610493749827543	-5.0986574092646	85	7	0.033175355450237	211	8202	3667,2254,4193,1026,2263,1956,5290	IRS1,FGF9,MDM2,CDKN1A,FGFR2,EGFR,PIK3CA
R-HSA-2142850	Hyaluronan biosynthesis and export	0.00625796574937758	-5.07390010684445	5	2	0.00947867298578199	211	8202	3038,57214	HAS3,CEMIP
R-HSA-70370	Galactose catabolism	0.00625796574937758	-5.07390010684445	5	2	0.00947867298578199	211	8202	5236,2582	PGM1,GALE
R-HSA-909733	Interferon alpha/beta signaling	0.00784511731246081	-4.84786393912172	68	6	0.028436018957346	211	8202	3107,4940,9636,6773,6772,3659	HLA-C,OAS3,ISG15,STAT2,STAT1,IRF1
R-HSA-2142845	Hyaluronan metabolism	0.00874364765382599	-4.73942782468535	17	3	0.014218009478673	211	8202	960,3038,57214	CD44,HAS3,CEMIP
R-HSA-1980143	Signaling by NOTCH1	0.0102926884545407	-4.57632149459805	72	6	0.028436018957346	211	8202	7088,182,54492,92737,57534,23220	TLE1,JAG1,NEURL1B,DNER,MIB1,DTX4
R-HSA-420597	Nectin/Necl  trans heterodimerization	0.0127021144628748	-4.36598680623629	7	2	0.00947867298578199	211	8202	81607,25945	PVRL4,PVRL3
R-HSA-1250342	PI3K events in ERBB4 signaling	0.0129507723338895	-4.34659985293238	98	7	0.033175355450237	211	8202	3667,2254,4193,1026,2263,1956,5290	IRS1,FGF9,MDM2,CDKN1A,FGFR2,EGFR,PIK3CA
R-HSA-5654720	PI-3K cascade:FGFR4	0.0129507723338895	-4.34659985293238	98	7	0.033175355450237	211	8202	3667,2254,4193,1026,2263,1956,5290	IRS1,FGF9,MDM2,CDKN1A,FGFR2,EGFR,PIK3CA
R-HSA-5654689	PI-3K cascade:FGFR1	0.0129507723338895	-4.34659985293238	98	7	0.033175355450237	211	8202	3667,2254,4193,1026,2263,1956,5290	IRS1,FGF9,MDM2,CDKN1A,FGFR2,EGFR,PIK3CA
R-HSA-5654695	PI-3K cascade:FGFR2	0.0129507723338895	-4.34659985293238	98	7	0.033175355450237	211	8202	3667,2254,4193,1026,2263,1956,5290	IRS1,FGF9,MDM2,CDKN1A,FGFR2,EGFR,PIK3CA
R-HSA-5654710	PI-3K cascade:FGFR3	0.0129507723338895	-4.34659985293238	98	7	0.033175355450237	211	8202	3667,2254,4193,1026,2263,1956,5290	IRS1,FGF9,MDM2,CDKN1A,FGFR2,EGFR,PIK3CA
R-HSA-1257604	PIP3 activates AKT signaling	0.0129507723338895	-4.34659985293238	98	7	0.033175355450237	211	8202	3667,2254,4193,1026,2263,1956,5290	IRS1,FGF9,MDM2,CDKN1A,FGFR2,EGFR,PIK3CA
R-HSA-1963642	PI3K events in ERBB2 signaling	0.0129507723338895	-4.34659985293238	98	7	0.033175355450237	211	8202	3667,2254,4193,1026,2263,1956,5290	IRS1,FGF9,MDM2,CDKN1A,FGFR2,EGFR,PIK3CA
R-HSA-202733	Cell surface interactions at the vascular wall	0.0136415547132729	-4.29463465115076	99	7	0.033175355450237	211	8202	3685,3675,960,3635,9123,965,5290	ITGAV,ITGA3,CD44,INPP5D,SLC16A3,CD58,PIK3CA
R-HSA-3000178	ECM proteoglycans	0.0141731348248579	-4.2564070200466	56	5	0.023696682464455	211	8202	3910,3913,3685,1462,3912	LAMA4,LAMB2,ITGAV,VCAN,LAMB1
R-HSA-1430728	Metabolism	0.014432632787178	-4.23826347050487	1691	57	0.270142180094787	211	8202	1591,8760,4719,6819,3635,27242,57214,84803,6513,9123,10162,5720,51477,79642,79586,1119,85441,1890,8824,3038,6307,64428,2232,5290,7385,2941,960,5631,204962,6576,4907,3156,516,10484,5236,10678,7390,5468,6303,7108,9517,51129,123,54331,847,50484,1462,51,8821,5243,51495,8714,4190,4048,66002,37,2582	CYP24A1,CDS2,NDUFS1,SULT1C2,INPP5D,TNFRSF21,CEMIP,GPAT3,SLC2A1,SLC16A3,LPCAT3,PSME1,ISYNA1,ARSJ,CHPF,CHKA,HELZ2,TYMP,CES2,HAS3,MSMO1,NARFL,FDXR,PIK3CA,UQCRC2,GSTA4,CD44,PRPS1,SLC44A5,SLC25A1,NT5E,HMGCR,ATP5G1,SEC23A,PGM1,B3GNT2,UROS,PPARG,SAT1,TM7SF2,SPTLC2,ANGPTL4,PLIN2,GNG2,CAT,RRM2B,VCAN,ACOX1,INPP4B,ABCB1,HACD3,ABCC3,MDH1,LTA4H,CYP4F12,ACADVL,GALE
R-HSA-198203	PI3K/AKT activation	0.0151017808158285	-4.19294260729194	101	7	0.033175355450237	211	8202	3667,2254,4193,1026,2263,1956,5290	IRS1,FGF9,MDM2,CDKN1A,FGFR2,EGFR,PIK3CA
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.0158563424679504	-4.14418570299314	38	4	0.018957345971564	211	8202	2934,7431,5588,4000	GSN,VIM,PRKCQ,LMNA
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.0158603241034554	-4.14393462770962	21	3	0.014218009478673	211	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-180292	GAB1 signalosome	0.0158722195047003	-4.14318489885403	102	7	0.033175355450237	211	8202	3667,2254,4193,1026,2263,1956,5290	IRS1,FGF9,MDM2,CDKN1A,FGFR2,EGFR,PIK3CA
R-HSA-418555	G alpha (s) signalling events	0.0165113968285855	-4.10370441962675	127	8	0.037914691943128	211	8202	54331,7433,10846,5142,5734,136,5139,133	GNG2,VIPR1,PDE10A,PDE4B,PTGER4,ADORA2B,PDE3A,ADM
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.0166513778165594	-4.09526231423411	8	2	0.00947867298578199	211	8202	3685,1535	ITGAV,CYBA
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.0174961853442511	-4.04577240214234	104	7	0.033175355450237	211	8202	3667,2254,4193,1026,2263,1956,5290	IRS1,FGF9,MDM2,CDKN1A,FGFR2,EGFR,PIK3CA
R-HSA-3371571	HSF1-dependent transactivation	0.018023019800675	-4.01610546033838	22	3	0.014218009478673	211	8202	817,3337,3304	CAMK2D,DNAJB1,HSPA1B
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.0199235229168583	-3.91585418920644	61	5	0.023696682464455	211	8202	3667,2254,2263,1956,5290	IRS1,FGF9,FGFR2,EGFR,PIK3CA
R-HSA-1474244	Extracellular matrix organization	0.0202171701759156	-3.9012230269191	267	13	0.0616113744075829	211	8202	3910,650,1308,3675,1462,3912,1291,3913,3685,3691,960,4325,823	LAMA4,BMP2,COL17A1,ITGA3,VCAN,LAMB1,COL6A1,LAMB2,ITGAV,ITGB4,CD44,MMP16,CAPN1
R-HSA-191273	Cholesterol biosynthesis	0.0203414930422586	-3.89509248681485	23	3	0.014218009478673	211	8202	7108,6307,3156	TM7SF2,MSMO1,HMGCR
R-HSA-5663202	Diseases of signal transduction	0.0207793170682707	-3.87379715870816	268	13	0.0616113744075829	211	8202	3667,2254,182,4193,2263,6772,5290,5720,54894,1026,54492,1956,57534	IRS1,FGF9,JAG1,MDM2,FGFR2,STAT1,PIK3CA,PSME1,RNF43,CDKN1A,NEURL1B,EGFR,MIB1
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.0208143759207698	-3.87211138097205	212	11	0.0521327014218009	211	8202	123,85441,5468,27242,51,84803,51495,37,51129,6576,3156	PLIN2,HELZ2,PPARG,TNFRSF21,ACOX1,GPAT3,HACD3,ACADVL,ANGPTL4,SLC25A1,HMGCR
R-HSA-446107	Type I hemidesmosome assembly	0.021049699638427	-3.86086898791389	9	2	0.00947867298578199	211	8202	1308,3691	COL17A1,ITGB4
R-HSA-109581	Apoptosis	0.0221498073038476	-3.80992648212939	160	9	0.042654028436019	211	8202	2934,581,8737,5720,5588,7431,317,2810,4000	GSN,BAX,RIPK1,PSME1,PRKCQ,VIM,APAF1,SFN,LMNA
R-HSA-5365859	RA biosynthesis pathway	0.0228161968696036	-3.78028460621088	24	3	0.014218009478673	211	8202	9249,220,157506	DHRS3,ALDH1A3,RDH10
R-HSA-157118	Signaling by NOTCH	0.0230663627719468	-3.76937987973999	110	7	0.033175355450237	211	8202	3725,7088,182,54492,92737,57534,23220	JUN,TLE1,JAG1,NEURL1B,DNER,MIB1,DTX4
R-HSA-5357801	Programmed Cell Death	0.0246329553785745	-3.70367008303811	163	9	0.042654028436019	211	8202	2934,581,8737,5720,5588,7431,317,2810,4000	GSN,BAX,RIPK1,PSME1,PRKCQ,VIM,APAF1,SFN,LMNA
R-HSA-1989781	PPARA activates gene expression	0.0251676438815081	-3.68219608242032	112	7	0.033175355450237	211	8202	123,85441,5468,27242,51129,51,3156	PLIN2,HELZ2,PPARG,TNFRSF21,ANGPTL4,ACOX1,HMGCR
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.025725432820932	-3.66027517248881	1	1	0.004739336492891	211	8202	2263	FGFR2
R-HSA-74259	Purine catabolism	0.0258715874203915	-3.65460992322911	10	2	0.00947867298578199	211	8202	847,4907	CAT,NT5E
R-HSA-1226099	Signaling by FGFR in disease	0.0278695995429118	-3.58021880634243	45	4	0.018957345971564	211	8202	2254,2263,6772,5290	FGF9,FGFR2,STAT1,PIK3CA
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.0282342615331756	-3.56721909050517	26	3	0.014218009478673	211	8202	8737,23220,1660	RIPK1,DTX4,DHX9
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.0285601308682537	-3.55574355929948	115	7	0.033175355450237	211	8202	123,85441,5468,27242,51129,51,3156	PLIN2,HELZ2,PPARG,TNFRSF21,ANGPTL4,ACOX1,HMGCR
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.0302722205310353	-3.49752480115521	312	14	0.0663507109004739	211	8202	3667,2254,817,1535,2905,2263,5290,5720,3685,26999,7414,9564,9475,1956	IRS1,FGF9,CAMK2D,CYBA,GRIN2C,FGFR2,PIK3CA,PSME1,ITGAV,CYFIP2,VCL,BCAR1,ROCK2,EGFR
R-HSA-877300	Interferon gamma signaling	0.0308960483668262	-3.4771269878251	92	6	0.028436018957346	211	8202	817,3107,4940,960,6772,3659	CAMK2D,HLA-C,OAS3,CD44,STAT1,IRF1
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.0310925523410849	-3.47078696303875	11	2	0.00947867298578199	211	8202	51477,8821	ISYNA1,INPP4B
R-HSA-5655253	Signaling by FGFR2 in disease	0.0311767553347429	-3.46808248315535	27	3	0.014218009478673	211	8202	2254,2263,5290	FGF9,FGFR2,PIK3CA
R-HSA-1483257	Phospholipid metabolism	0.0344802537437659	-3.36736847405578	146	8	0.037914691943128	211	8202	8760,3635,84803,8821,5290,10162,204962,1119	CDS2,INPP5D,GPAT3,INPP4B,PIK3CA,LPCAT3,SLC44A5,CHKA
R-HSA-2262752	Cellular responses to stress	0.0349096473066175	-3.35499206084898	379	16	0.0758293838862559	211	8202	23043,10808,3397,475,23466,3337,1026,3304,6118,847,3725,1912,817,4193,51434,112399	TNIK,HSPH1,ID1,ATOX1,CBX6,DNAJB1,CDKN1A,HSPA1B,RPA2,CAT,JUN,PHC2,CAMK2D,MDM2,ANAPC7,EGLN3
R-HSA-194138	Signaling by VEGF	0.0363676733697173	-3.3140749931673	320	14	0.0663507109004739	211	8202	3667,2254,817,1535,2905,2263,5290,5720,3685,26999,7414,9564,9475,1956	IRS1,FGF9,CAMK2D,CYBA,GRIN2C,FGFR2,PIK3CA,PSME1,ITGAV,CYFIP2,VCL,BCAR1,ROCK2,EGFR
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.0366890748909397	-3.30527625513453	12	2	0.00947867298578199	211	8202	2934,7431	GSN,VIM
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	0.0366890748909397	-3.30527625513453	12	2	0.00947867298578199	211	8202	891,2810	CCNB1,SFN
R-HSA-210990	PECAM1 interactions	0.0366890748909397	-3.30527625513453	12	2	0.00947867298578199	211	8202	3685,3635	ITGAV,INPP5D
R-HSA-73621	Pyrimidine catabolism	0.0366890748909397	-3.30527625513453	12	2	0.00947867298578199	211	8202	1890,4907	TYMP,NT5E
R-HSA-1839124	FGFR1 mutant receptor activation	0.0375241914833952	-3.28276944777347	29	3	0.014218009478673	211	8202	2254,6772,5290	FGF9,STAT1,PIK3CA
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.0385866726422911	-3.25484833046461	97	6	0.028436018957346	211	8202	3725,8737,10010,1326,3656,1660	JUN,RIPK1,TANK,MAP3K8,IRAK2,DHX9
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.0385866726422911	-3.25484833046461	97	6	0.028436018957346	211	8202	3725,8737,10010,1326,3656,1660	JUN,RIPK1,TANK,MAP3K8,IRAK2,DHX9
R-HSA-373760	L1CAM interactions	0.0385866726422911	-3.25484833046461	97	6	0.028436018957346	211	8202	6386,3685,214,160,3912,1956	SDCBP,ITGAV,ALCAM,AP2A1,LAMB1,EGFR
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.0385866726422911	-3.25484833046461	97	6	0.028436018957346	211	8202	3725,8737,10010,1326,3656,1660	JUN,RIPK1,TANK,MAP3K8,IRAK2,DHX9
R-HSA-399719	Trafficking of AMPA receptors	0.0409265120859469	-3.19597720867513	30	3	0.014218009478673	211	8202	817,4193,160	CAMK2D,MDM2,AP2A1
R-HSA-5656169	Termination of translesion DNA synthesis	0.0409265120859469	-3.19597720867513	30	3	0.014218009478673	211	8202	6118,5429,9636	RPA2,POLH,ISG15
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.0409265120859469	-3.19597720867513	30	3	0.014218009478673	211	8202	817,4193,160	CAMK2D,MDM2,AP2A1
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.0426385715891531	-3.15499599900196	13	2	0.00947867298578199	211	8202	4193,1026	MDM2,CDKN1A
R-HSA-190375	FGFR2c ligand binding and activation	0.0426385715891531	-3.15499599900196	13	2	0.00947867298578199	211	8202	2254,2263	FGF9,FGFR2
R-HSA-75153	Apoptotic execution  phase	0.0441365079437892	-3.12046799447326	52	4	0.018957345971564	211	8202	2934,7431,5588,4000	GSN,VIM,PRKCQ,LMNA
R-HSA-1980145	Signaling by NOTCH2	0.0481799647198607	-3.03281201405262	32	3	0.014218009478673	211	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-3371568	Attenuation phase	0.0489193627664976	-3.01758199428035	14	2	0.00947867298578199	211	8202	3337,3304	DNAJB1,HSPA1B
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.0495820716621359	-3.00412596901778	54	4	0.018957345971564	211	8202	7108,10484,85441,3156	TM7SF2,SEC23A,HELZ2,HMGCR
R-HSA-71387	Metabolism of carbohydrates	0.0501648914555138	-2.99243987035625	274	12	0.0568720379146919	211	8202	5236,10678,3038,57214,1462,6513,4190,960,5631,6576,79586,2582	PGM1,B3GNT2,HAS3,CEMIP,VCAN,SLC2A1,MDH1,CD44,PRPS1,SLC25A1,CHPF,GALE
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.0507921239153605	-2.98001397745402	2	1	0.004739336492891	211	8202	3304	HSPA1B
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.0507921239153605	-2.98001397745402	2	1	0.004739336492891	211	8202	1026	CDKN1A
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.0507921239153605	-2.98001397745402	2	1	0.004739336492891	211	8202	1956	EGFR
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.0507921239153605	-2.98001397745402	2	1	0.004739336492891	211	8202	1026	CDKN1A
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.0507921239153605	-2.98001397745402	2	1	0.004739336492891	211	8202	581	BAX
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.0507921239153605	-2.98001397745402	2	1	0.004739336492891	211	8202	1956	EGFR
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.0520270817095673	-2.955990893864	33	3	0.014218009478673	211	8202	3635,8821,5290	INPP5D,INPP4B,PIK3CA
R-HSA-109704	PI3K Cascade	0.052350282281048	-2.94979794949201	79	5	0.023696682464455	211	8202	51719,3667,2254,2263,5290	CAB39,IRS1,FGF9,FGFR2,PIK3CA
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.0555106413665197	-2.89118054027512	15	2	0.00947867298578199	211	8202	891,4000	CCNB1,LMNA
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.0555106413665197	-2.89118054027512	15	2	0.00947867298578199	211	8202	1956,5290	EGFR,PIK3CA
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.0555106413665197	-2.89118054027512	15	2	0.00947867298578199	211	8202	1956,5290	EGFR,PIK3CA
R-HSA-1236975	Antigen processing-Cross presentation	0.0571609295245855	-2.86188466425099	81	5	0.023696682464455	211	8202	5720,6892,3107,3685,1535	PSME1,TAPBP,HLA-C,ITGAV,CYBA
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.0571609295245855	-2.86188466425099	81	5	0.023696682464455	211	8202	8737,10010,9636,3659,1660	RIPK1,TANK,ISG15,IRF1,DHX9
R-HSA-449147	Signaling by Interleukins	0.0576823255253661	-2.85280446911072	311	13	0.0616113744075829	211	8202	3667,2254,817,2263,2905,3635,1326,3656,6772,5290,5720,7414,1956	IRS1,FGF9,CAMK2D,FGFR2,GRIN2C,INPP5D,MAP3K8,IRAK2,STAT1,PIK3CA,PSME1,VCL,EGFR
R-HSA-186797	Signaling by PDGF	0.0610543453673775	-2.79599090376958	345	14	0.0663507109004739	211	8202	3667,2254,817,4193,2905,2263,1291,6772,5290,5720,1026,7414,9564,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,COL6A1,STAT1,PIK3CA,PSME1,CDKN1A,VCL,BCAR1,EGFR
R-HSA-5655302	Signaling by FGFR1 in disease	0.0644219480652523	-2.74230089546719	36	3	0.014218009478673	211	8202	2254,6772,5290	FGF9,STAT1,PIK3CA
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.0680174387385087	-2.68799115464734	168	8	0.037914691943128	211	8202	3667,2254,4193,2263,5290,5720,1026,1956	IRS1,FGF9,MDM2,FGFR2,PIK3CA,PSME1,CDKN1A,EGFR
R-HSA-166054	Activated TLR4 signalling	0.0685129350256918	-2.68073271904872	112	6	0.028436018957346	211	8202	3725,8737,10010,1326,3656,1660	JUN,RIPK1,TANK,MAP3K8,IRAK2,DHX9
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.0688293315621517	-2.67612529405078	37	3	0.014218009478673	211	8202	6118,5429,9636	RPA2,POLH,ISG15
R-HSA-2033519	Activated point mutants of FGFR2	0.0695456154216735	-2.66577240470383	17	2	0.00947867298578199	211	8202	2254,2263	FGF9,FGFR2
R-HSA-1839126	FGFR2 mutant receptor activation	0.0695456154216735	-2.66577240470383	17	2	0.00947867298578199	211	8202	2254,2263	FGF9,FGFR2
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.0695456154216735	-2.66577240470383	17	2	0.00947867298578199	211	8202	817,2905	CAMK2D,GRIN2C
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.0695456154216735	-2.66577240470383	17	2	0.00947867298578199	211	8202	817,2905	CAMK2D,GRIN2C
R-HSA-176412	Phosphorylation of the APC/C	0.0695456154216735	-2.66577240470383	17	2	0.00947867298578199	211	8202	51434,891	ANAPC7,CCNB1
R-HSA-3371556	Cellular response to heat stress	0.0702625986910678	-2.6555156460498	86	5	0.023696682464455	211	8202	6118,10808,817,3337,3304	RPA2,HSPH1,CAMK2D,DNAJB1,HSPA1B
R-HSA-186763	Downstream signal transduction	0.0717133740107211	-2.63507802142444	322	13	0.0616113744075829	211	8202	3667,2254,817,4193,2905,2263,6772,5290,5720,1026,7414,9564,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,STAT1,PIK3CA,PSME1,CDKN1A,VCL,BCAR1,EGFR
R-HSA-422475	Axon guidance	0.0719690654050195	-2.63151889944337	516	19	0.0900473933649289	211	8202	1948,2254,5588,5720,214,1956,3667,817,2263,2905,160,1291,3912,6386,3685,7414,10371,7074,9475	EFNB2,FGF9,PRKCQ,PSME1,ALCAM,EGFR,IRS1,CAMK2D,FGFR2,GRIN2C,AP2A1,COL6A1,LAMB1,SDCBP,ITGAV,VCL,SEMA3A,TIAM1,ROCK2
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.0733698734848661	-2.61224187060192	38	3	0.014218009478673	211	8202	317,2810,581	APAF1,SFN,BAX
R-HSA-5653890	Lactose synthesis	0.0752168631654731	-2.5873798289436	3	1	0.004739336492891	211	8202	6513	SLC2A1
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.0752168631654731	-2.5873798289436	3	1	0.004739336492891	211	8202	4121	MAN1A1
R-HSA-111458	Formation of apoptosome	0.0752168631654731	-2.5873798289436	3	1	0.004739336492891	211	8202	317	APAF1
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.0752168631654731	-2.5873798289436	3	1	0.004739336492891	211	8202	5631	PRPS1
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.0752168631654731	-2.5873798289436	3	1	0.004739336492891	211	8202	2232	FDXR
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.0752168631654731	-2.5873798289436	3	1	0.004739336492891	211	8202	37	ACADVL
R-HSA-352238	Breakdown of the nuclear lamina	0.0752168631654731	-2.5873798289436	3	1	0.004739336492891	211	8202	4000	LMNA
R-HSA-351200	Interconversion of polyamines	0.0752168631654731	-2.5873798289436	3	1	0.004739336492891	211	8202	6303	SAT1
R-HSA-1839117	Signaling by FGFR1 fusion mutants	0.0769517928029801	-2.56457612068431	18	2	0.00947867298578199	211	8202	6772,5290	STAT1,PIK3CA
R-HSA-418457	cGMP effects	0.0769517928029801	-2.56457612068431	18	2	0.00947867298578199	211	8202	10846,5139	PDE10A,PDE3A
R-HSA-6783310	Fanconi Anemia Pathway	0.0780405583289272	-2.55052660885857	39	3	0.014218009478673	211	8202	6118,2189,197342	RPA2,FANCG,EME2
R-HSA-1474228	Degradation of the extracellular matrix	0.0788542670962943	-2.5401538504071	89	5	0.023696682464455	211	8202	1308,960,4325,823,3912	COL17A1,CD44,MMP16,CAPN1,LAMB1
R-HSA-1643685	Disease	0.079477658448071	-2.53227932262743	657	23	0.109004739336493	211	8202	2254,6160,6235,6142,5720,54894,1026,54492,1956,9636,57534,3304,3667,4193,182,2263,1462,160,6170,2232,6772,5290,60489	FGF9,RPL31,RPS29,RPL18A,PSME1,RNF43,CDKN1A,NEURL1B,EGFR,ISG15,MIB1,HSPA1B,IRS1,MDM2,JAG1,FGFR2,VCAN,AP2A1,RPL39,FDXR,STAT1,PIK3CA,APOBEC3G
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.0845933657638041	-2.46989943431244	19	2	0.00947867298578199	211	8202	1956,5290	EGFR,PIK3CA
R-HSA-110320	Translesion Synthesis by POLH	0.0845933657638041	-2.46989943431244	19	2	0.00947867298578199	211	8202	6118,5429	RPA2,POLH
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.0845933657638041	-2.46989943431244	19	2	0.00947867298578199	211	8202	817,2905	CAMK2D,GRIN2C
R-HSA-3928664	Ephrin signaling	0.0845933657638041	-2.46989943431244	19	2	0.00947867298578199	211	8202	1948,6386	EFNB2,SDCBP
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.0845933657638041	-2.46989943431244	19	2	0.00947867298578199	211	8202	1956,5290	EGFR,PIK3CA
R-HSA-1643713	Signaling by EGFR in Cancer	0.0845933657638041	-2.46989943431244	19	2	0.00947867298578199	211	8202	1956,5290	EGFR,PIK3CA
R-HSA-5685942	HDR through Homologous Recombination (HRR)	0.0857369849602551	-2.45647098334482	65	4	0.018957345971564	211	8202	6118,672,5429,197342	RPA2,BRCA1,POLH,EME2
R-HSA-912526	Interleukin receptor SHC signaling	0.0867956660707717	-2.44419858862261	238	10	0.0473933649289099	211	8202	3667,2254,817,2263,2905,3635,5290,5720,7414,1956	IRS1,FGF9,CAMK2D,FGFR2,GRIN2C,INPP5D,PIK3CA,PSME1,VCL,EGFR
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.0877597862469212	-2.43315189867308	41	3	0.014218009478673	211	8202	7108,85441,3156	TM7SF2,HELZ2,HMGCR
R-HSA-69620	Cell Cycle Checkpoints	0.090441236580669	-2.40305495872611	179	8	0.037914691943128	211	8202	6118,4193,5720,51434,1026,672,891,2810	RPA2,MDM2,PSME1,ANAPC7,CDKN1A,BRCA1,CCNB1,SFN
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.091511145787364	-2.39129450223537	121	6	0.028436018957346	211	8202	3725,8737,10010,1326,3656,1660	JUN,RIPK1,TANK,MAP3K8,IRAK2,DHX9
R-HSA-1483191	Synthesis of PC	0.0924534561481521	-2.38104993787641	20	2	0.00947867298578199	211	8202	204962,1119	SLC44A5,CHKA
R-HSA-190241	FGFR2 ligand binding and activation	0.0924534561481521	-2.38104993787641	20	2	0.00947867298578199	211	8202	2254,2263	FGF9,FGFR2
R-HSA-3000170	Syndecan interactions	0.0924534561481521	-2.38104993787641	20	2	0.00947867298578199	211	8202	3685,3691	ITGAV,ITGB4
R-HSA-3928662	EPHB-mediated forward signaling	0.0928018238446704	-2.37728898588451	42	3	0.014218009478673	211	8202	1948,7074,9475	EFNB2,TIAM1,ROCK2
R-HSA-1630316	Glycosaminoglycan metabolism	0.0971284319128622	-2.33172113590843	123	6	0.028436018957346	211	8202	10678,960,3038,57214,1462,79586	B3GNT2,CD44,HAS3,CEMIP,VCAN,CHPF
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.0973379172708421	-2.32956667124253	68	4	0.018957345971564	211	8202	6118,10808,3337,3304	RPA2,HSPH1,DNAJB1,HSPA1B
R-HSA-2682334	EPH-Ephrin signaling	0.0976423110978108	-2.3264443641573	95	5	0.023696682464455	211	8202	1948,6386,7074,160,9475	EFNB2,SDCBP,TIAM1,AP2A1,ROCK2
R-HSA-1433557	Signaling by SCF-KIT	0.0977605513627355	-2.32523414361224	307	12	0.0568720379146919	211	8202	3667,2254,817,4193,2905,2263,6772,5290,5720,1026,7414,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,STAT1,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-917937	Iron uptake and transport	0.0979610146688534	-2.32318568896025	43	3	0.014218009478673	211	8202	2495,30061,523	FTH1,SLC40A1,ATP6V1A
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.0990160145102342	-2.31247367920009	4	1	0.004739336492891	211	8202	2232	FDXR
R-HSA-417973	Adenosine P1 receptors	0.0990160145102342	-2.31247367920009	4	1	0.004739336492891	211	8202	136	ADORA2B
R-HSA-433692	Proton-coupled monocarboxylate transport	0.0990160145102342	-2.31247367920009	4	1	0.004739336492891	211	8202	9123	SLC16A3
R-HSA-1280215	Cytokine Signaling in Immune system	0.0997174067144372	-2.30541502633644	539	19	0.0900473933649289	211	8202	2254,3635,1326,5720,1956,9636,6773,3667,817,2905,2263,3656,6772,5290,4940,3107,960,7414,3659	FGF9,INPP5D,MAP3K8,PSME1,EGFR,ISG15,STAT2,IRS1,CAMK2D,GRIN2C,FGFR2,IRAK2,STAT1,PIK3CA,OAS3,HLA-C,CD44,VCL,IRF1
R-HSA-1266738	Developmental Biology	0.100192683869875	-2.30066010826783	710	24	0.113744075829384	211	8202	1948,2254,5468,5087,5588,5720,214,51129,1956,3667,85441,817,2905,2263,160,3912,1291,6386,3685,7026,7414,10371,7074,9475	EFNB2,FGF9,PPARG,PBX1,PRKCQ,PSME1,ALCAM,ANGPTL4,EGFR,IRS1,HELZ2,CAMK2D,GRIN2C,FGFR2,AP2A1,LAMB1,COL6A1,SDCBP,ITGAV,NR2F2,VCL,SEMA3A,TIAM1,ROCK2
R-HSA-451927	Interleukin-2 signaling	0.100296567325903	-2.29962380866867	245	10	0.0473933649289099	211	8202	3667,2254,817,2263,2905,3635,5290,5720,7414,1956	IRS1,FGF9,CAMK2D,FGFR2,GRIN2C,INPP5D,PIK3CA,PSME1,VCL,EGFR
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.100515891102616	-2.29743944355868	21	2	0.00947867298578199	211	8202	1462,79586	VCAN,CHPF
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.100515891102616	-2.29743944355868	21	2	0.00947867298578199	211	8202	1326,5290	MAP3K8,PIK3CA
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	0.100515891102616	-2.29743944355868	21	2	0.00947867298578199	211	8202	8737,1660	RIPK1,DHX9
R-HSA-445144	Signal transduction by L1	0.100515891102616	-2.29743944355868	21	2	0.00947867298578199	211	8202	3685,1956	ITGAV,EGFR
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.100515891102616	-2.29743944355868	21	2	0.00947867298578199	211	8202	51434,891	ANAPC7,CCNB1
R-HSA-1483206	Glycerophospholipid biosynthesis	0.100976515101274	-2.29286731292848	96	5	0.023696682464455	211	8202	10162,8760,84803,204962,1119	LPCAT3,CDS2,GPAT3,SLC44A5,CHKA
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.102563774494942	-2.27727048368919	342	13	0.0616113744075829	211	8202	3725,3667,2254,817,4193,2263,2905,5290,5588,5720,1026,7414,1956	JUN,IRS1,FGF9,CAMK2D,MDM2,FGFR2,GRIN2C,PIK3CA,PRKCQ,PSME1,CDKN1A,VCL,EGFR
R-HSA-5362517	Signaling by Retinoic Acid	0.103233932582163	-2.27075767588816	44	3	0.014218009478673	211	8202	9249,220,157506	DHRS3,ALDH1A3,RDH10
R-HSA-382556	ABC-family proteins mediated transport	0.103233932582163	-2.27075767588816	44	3	0.014218009478673	211	8202	8714,5825,5243	ABCC3,ABCD3,ABCB1
R-HSA-5655332	Signaling by FGFR3 in disease	0.108765178232195	-2.21856404880111	22	2	0.00947867298578199	211	8202	2254,5290	FGF9,PIK3CA
R-HSA-2559583	Cellular Senescence	0.109146774140777	-2.21506175079052	187	8	0.037914691943128	211	8202	1912,3725,23043,4193,3397,23466,51434,1026	PHC2,JUN,TNIK,MDM2,ID1,CBX6,ANAPC7,CDKN1A
R-HSA-109582	Hemostasis	0.113595218463255	-2.17511386457341	515	18	0.0853080568720379	211	8202	3920,3635,9123,5588,9564,5139,2152,965,54331,6281,3675,10846,5290,3685,50808,960,7414,3659	LAMP2,INPP5D,SLC16A3,PRKCQ,BCAR1,PDE3A,F3,CD58,GNG2,S100A10,ITGA3,PDE10A,PIK3CA,ITGAV,AK3,CD44,VCL,IRF1
R-HSA-1483249	Inositol phosphate metabolism	0.114106992701054	-2.17061873826848	46	3	0.014218009478673	211	8202	51477,3635,8821	ISYNA1,INPP5D,INPP4B
R-HSA-73893	DNA Damage Bypass	0.114106992701054	-2.17061873826848	46	3	0.014218009478673	211	8202	6118,5429,9636	RPA2,POLH,ISG15
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.118196290446683	-2.13540855820242	73	4	0.018957345971564	211	8202	143686,27244,50484,2810	SESN3,SESN1,RRM2B,SFN
R-HSA-3700989	Transcriptional Regulation by TP53	0.118196290446683	-2.13540855820242	73	4	0.018957345971564	211	8202	143686,27244,50484,2810	SESN3,SESN1,RRM2B,SFN
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.119366528648276	-2.12555644690225	254	10	0.0473933649289099	211	8202	3667,2254,817,2263,2905,3635,5290,5720,7414,1956	IRS1,FGF9,CAMK2D,FGFR2,GRIN2C,INPP5D,PIK3CA,PSME1,VCL,EGFR
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	0.122205526700029	-2.10205100658952	5	1	0.004739336492891	211	8202	2152	F3
R-HSA-446205	Synthesis of GDP-mannose	0.122205526700029	-2.10205100658952	5	1	0.004739336492891	211	8202	29926	GMPPA
R-HSA-74713	IRS activation	0.122205526700029	-2.10205100658952	5	1	0.004739336492891	211	8202	3667	IRS1
R-HSA-2161517	Abacavir transmembrane transport	0.122205526700029	-2.10205100658952	5	1	0.004739336492891	211	8202	5243	ABCB1
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.122205526700029	-2.10205100658952	5	1	0.004739336492891	211	8202	60489	APOBEC3G
R-HSA-111461	Cytochrome c-mediated apoptotic response	0.122205526700029	-2.10205100658952	5	1	0.004739336492891	211	8202	317	APAF1
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.122205526700029	-2.10205100658952	5	1	0.004739336492891	211	8202	4121	MAN1A1
R-HSA-69478	G2/M DNA replication checkpoint	0.122205526700029	-2.10205100658952	5	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	0.122205526700029	-2.10205100658952	5	1	0.004739336492891	211	8202	317	APAF1
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.125392703408638	-2.07630483901021	48	3	0.014218009478673	211	8202	1948,7074,160	EFNB2,TIAM1,AP2A1
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.125765598373753	-2.07333543496133	24	2	0.00947867298578199	211	8202	4193,1026	MDM2,CDKN1A
R-HSA-73848	Pyrimidine metabolism	0.125765598373753	-2.07333543496133	24	2	0.00947867298578199	211	8202	1890,4907	TYMP,NT5E
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.125765598373753	-2.07333543496133	24	2	0.00947867298578199	211	8202	10550,6505	ARL6IP5,SLC1A1
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.125765598373753	-2.07333543496133	24	2	0.00947867298578199	211	8202	10846,5139	PDE10A,PDE3A
R-HSA-416482	G alpha (12/13) signalling events	0.127041997140455	-2.06323756104284	75	4	0.018957345971564	211	8202	54331,7074,9475,5290	GNG2,TIAM1,ROCK2,PIK3CA
R-HSA-913531	Interferon Signaling	0.127130002505348	-2.06254507431313	194	8	0.037914691943128	211	8202	817,6772,4940,3107,960,6773,9636,3659	CAMK2D,STAT1,OAS3,HLA-C,CD44,STAT2,ISG15,IRF1
R-HSA-982772	Growth hormone receptor signaling	0.134488936501435	-2.0062733398184	25	2	0.00947867298578199	211	8202	3667,6772	IRS1,STAT1
R-HSA-210991	Basigin interactions	0.134488936501435	-2.0062733398184	25	2	0.00947867298578199	211	8202	3675,9123	ITGA3,SLC16A3
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.138061330413123	-1.98005726926821	198	8	0.037914691943128	211	8202	3667,2254,4193,2263,5290,5720,1026,1956	IRS1,FGF9,MDM2,FGFR2,PIK3CA,PSME1,CDKN1A,EGFR
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.140812661200027	-1.96032491600541	78	4	0.018957345971564	211	8202	85441,7026,5468,51129	HELZ2,NR2F2,PPARG,ANGPTL4
R-HSA-1483255	PI Metabolism	0.143032039350572	-1.9446866224154	51	3	0.014218009478673	211	8202	3635,8821,5290	INPP5D,INPP4B,PIK3CA
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.143343492748315	-1.94251148183508	26	2	0.00947867298578199	211	8202	3656,1660	IRAK2,DHX9
R-HSA-912694	Regulation of IFNA signaling	0.143343492748315	-1.94251148183508	26	2	0.00947867298578199	211	8202	6773,6772	STAT2,STAT1
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.143343492748315	-1.94251148183508	26	2	0.00947867298578199	211	8202	2254,2263	FGF9,FGFR2
R-HSA-3238698	WNT ligand biogenesis and trafficking	0.143343492748315	-1.94251148183508	26	2	0.00947867298578199	211	8202	51384,79971	WNT16,WLS
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.144800943787179	-1.9323952811845	6	1	0.004739336492891	211	8202	51	ACOX1
R-HSA-176417	Phosphorylation of Emi1	0.144800943787179	-1.9323952811845	6	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.144800943787179	-1.9323952811845	6	1	0.004739336492891	211	8202	2517	FUCA1
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.144800943787179	-1.9323952811845	6	1	0.004739336492891	211	8202	2232	FDXR
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.144800943787179	-1.9323952811845	6	1	0.004739336492891	211	8202	23220	DTX4
R-HSA-211916	Vitamins	0.144800943787179	-1.9323952811845	6	1	0.004739336492891	211	8202	1591	CYP24A1
R-HSA-3000484	Scavenging by Class F Receptors	0.144800943787179	-1.9323952811845	6	1	0.004739336492891	211	8202	10808	HSPH1
R-HSA-168898	Toll-Like Receptors Cascades	0.151867127660645	-1.88474930056397	140	6	0.028436018957346	211	8202	3725,8737,10010,1326,3656,1660	JUN,RIPK1,TANK,MAP3K8,IRAK2,DHX9
R-HSA-182971	EGFR downregulation	0.152316831739383	-1.88179250818572	27	2	0.00947867298578199	211	8202	160,1956	AP2A1,EGFR
R-HSA-1368082	RORA activates gene expression	0.152316831739383	-1.88179250818572	27	2	0.00947867298578199	211	8202	85441,8204	HELZ2,NRIP1
R-HSA-381038	XBP1(S) activates chaperone genes	0.15522318013476	-1.86289132584719	53	3	0.014218009478673	211	8202	37,4189,4000	ACADVL,DNAJB9,LMNA
R-HSA-177929	Signaling by EGFR	0.15664925924478	-1.85374599032298	336	12	0.0568720379146919	211	8202	3667,2254,817,4193,2905,2263,160,5290,5720,1026,7414,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,AP2A1,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-168249	Innate Immune System	0.157380904874298	-1.84908626627753	752	24	0.113744075829384	211	8202	2254,1326,1660,8737,5588,5720,1026,26999,837,1956,9636,3667,3725,817,4193,2905,2263,10010,3656,5290,23220,3107,7414,3659	FGF9,MAP3K8,DHX9,RIPK1,PRKCQ,PSME1,CDKN1A,CYFIP2,CASP4,EGFR,ISG15,IRS1,JUN,CAMK2D,MDM2,GRIN2C,FGFR2,TANK,IRAK2,PIK3CA,DTX4,HLA-C,VCL,IRF1
R-HSA-74752	Signaling by Insulin receptor	0.160027134738886	-1.83241188600939	304	11	0.0521327014218009	211	8202	3667,2254,817,2905,523,2263,5290,51719,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,ATP6V1A,FGFR2,PIK3CA,CAB39,PSME1,VCL,EGFR
R-HSA-15869	Metabolism of nucleotides	0.160045752253419	-1.8322955530408	82	4	0.018957345971564	211	8202	847,1890,50484,4907	CAT,TYMP,RRM2B,NT5E
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.160045752253419	-1.8322955530408	82	4	0.018957345971564	211	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.160045752253419	-1.8322955530408	82	4	0.018957345971564	211	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.160045752253419	-1.8322955530408	82	4	0.018957345971564	211	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.164999070346974	-1.80181543935819	83	4	0.018957345971564	211	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-5683057	MAPK family signaling cascades	0.165709545509944	-1.79751874902753	273	10	0.0473933649289099	211	8202	3725,3667,2254,817,2905,2263,5720,3337,7414,1956	JUN,IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,DNAJB1,VCL,EGFR
R-HSA-2172127	DAP12 interactions	0.165977706417078	-1.79590179833677	340	12	0.0568720379146919	211	8202	3667,2254,817,4193,2263,2905,5290,5720,1026,3107,7414,1956	IRS1,FGF9,CAMK2D,MDM2,FGFR2,GRIN2C,PIK3CA,PSME1,CDKN1A,HLA-C,VCL,EGFR
R-HSA-182218	Nef Mediated CD8 Down-regulation	0.166817415342637	-1.79085538597869	7	1	0.004739336492891	211	8202	160	AP2A1
R-HSA-447043	Neurofascin interactions	0.166817415342637	-1.79085538597869	7	1	0.004739336492891	211	8202	6386	SDCBP
R-HSA-111471	Apoptotic factor-mediated response	0.166817415342637	-1.79085538597869	7	1	0.004739336492891	211	8202	317	APAF1
R-HSA-196791	Vitamin D (calciferol) metabolism	0.166817415342637	-1.79085538597869	7	1	0.004739336492891	211	8202	1591	CYP24A1
R-HSA-3595177	Defective CHSY1 causes TPBS	0.166817415342637	-1.79085538597869	7	1	0.004739336492891	211	8202	1462	VCAN
R-HSA-190371	FGFR3b ligand binding and activation	0.166817415342637	-1.79085538597869	7	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.166817415342637	-1.79085538597869	7	1	0.004739336492891	211	8202	182	JAG1
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	0.166817415342637	-1.79085538597869	7	1	0.004739336492891	211	8202	1462	VCAN
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	0.166817415342637	-1.79085538597869	7	1	0.004739336492891	211	8202	9249	DHRS3
R-HSA-3595172	Defective CHST3 causes SEDCJD	0.166817415342637	-1.79085538597869	7	1	0.004739336492891	211	8202	1462	VCAN
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.166817415342637	-1.79085538597869	7	1	0.004739336492891	211	8202	182	JAG1
R-HSA-427601	Multifunctional anion exchangers	0.166817415342637	-1.79085538597869	7	1	0.004739336492891	211	8202	65010	SLC26A6
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	0.166817415342637	-1.79085538597869	7	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	0.166817415342637	-1.79085538597869	7	1	0.004739336492891	211	8202	8313	AXIN2
R-HSA-381070	IRE1alpha activates chaperones	0.167725817536207	-1.78542467127941	55	3	0.014218009478673	211	8202	37,4189,4000	ACADVL,DNAJB9,LMNA
R-HSA-192823	Viral mRNA Translation	0.170007113484284	-1.77191499878211	84	4	0.018957345971564	211	8202	6142,6170,6160,6235	RPL18A,RPL39,RPL31,RPS29
R-HSA-156902	Peptide chain elongation	0.170007113484284	-1.77191499878211	84	4	0.018957345971564	211	8202	6142,6170,6160,6235	RPL18A,RPL39,RPL31,RPS29
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.170572834007437	-1.76859289454426	29	2	0.00947867298578199	211	8202	85441,860	HELZ2,RUNX2
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.170572834007437	-1.76859289454426	29	2	0.00947867298578199	211	8202	847,475	CAT,ATOX1
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.170572834007437	-1.76859289454426	29	2	0.00947867298578199	211	8202	817,2905	CAMK2D,GRIN2C
R-HSA-5654716	Downstream signaling of activated FGFR4	0.175066938626744	-1.74258687175702	310	11	0.0521327014218009	211	8202	3667,2254,817,4193,2905,2263,5290,5720,1026,7414,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-5654687	Downstream signaling of activated FGFR1	0.175066938626744	-1.74258687175702	310	11	0.0521327014218009	211	8202	3667,2254,817,4193,2905,2263,5290,5720,1026,7414,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-5654708	Downstream signaling of activated FGFR3	0.175066938626744	-1.74258687175702	310	11	0.0521327014218009	211	8202	3667,2254,817,4193,2905,2263,5290,5720,1026,7414,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-5654696	Downstream signaling of activated FGFR2	0.175066938626744	-1.74258687175702	310	11	0.0521327014218009	211	8202	3667,2254,817,4193,2905,2263,5290,5720,1026,7414,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-72764	Eukaryotic Translation Termination	0.175068210538487	-1.74257960649533	85	4	0.018957345971564	211	8202	6142,6170,6160,6235	RPL18A,RPL39,RPL31,RPS29
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.175068210538487	-1.74257960649533	85	4	0.018957345971564	211	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.175068210538487	-1.74257960649533	85	4	0.018957345971564	211	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-112399	IRS-mediated signalling	0.176456168439632	-1.73468277090214	277	10	0.0473933649289099	211	8202	3667,2254,817,2905,2263,5290,51719,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PIK3CA,CAB39,PSME1,VCL,EGFR
R-HSA-168254	Influenza Infection	0.177718151791907	-1.72755640051888	147	6	0.028436018957346	211	8202	6142,6170,6160,9636,6235,3304	RPL18A,RPL39,RPL31,ISG15,RPS29,HSPA1B
R-HSA-2559585	Oncogene Induced Senescence	0.179833285571241	-1.71572504854297	30	2	0.00947867298578199	211	8202	4193,3397	MDM2,ID1
R-HSA-446728	Cell junction organization	0.180180679409709	-1.7137951570383	86	4	0.018957345971564	211	8202	81607,1308,3691,25945	PVRL4,COL17A1,ITGB4,PVRL3
R-HSA-1236394	Signaling by ERBB4	0.180227754825974	-1.71353392332643	312	11	0.0521327014218009	211	8202	3667,2254,817,4193,2905,2263,5290,5720,1026,7414,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.180511246185765	-1.71196219741181	57	3	0.014218009478673	211	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.180511246185765	-1.71196219741181	57	3	0.014218009478673	211	8202	5720,4193,1026	PSME1,MDM2,CDKN1A
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.180511246185765	-1.71196219741181	57	3	0.014218009478673	211	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.180511246185765	-1.71196219741181	57	3	0.014218009478673	211	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.180511246185765	-1.71196219741181	57	3	0.014218009478673	211	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.180511246185765	-1.71196219741181	57	3	0.014218009478673	211	8202	5720,4193,1026	PSME1,MDM2,CDKN1A
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.180511246185765	-1.71196219741181	57	3	0.014218009478673	211	8202	182,54492,57534	JAG1,NEURL1B,MIB1
R-HSA-5654741	Signaling by FGFR3	0.182835139129045	-1.69917041125241	313	11	0.0521327014218009	211	8202	3667,2254,817,4193,2905,2263,5290,5720,1026,7414,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-5654743	Signaling by FGFR4	0.182835139129045	-1.69917041125241	313	11	0.0521327014218009	211	8202	3667,2254,817,4193,2905,2263,5290,5720,1026,7414,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-74751	Insulin receptor signalling cascade	0.184726965833804	-1.68887640441627	280	10	0.0473933649289099	211	8202	3667,2254,817,2905,2263,5290,51719,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PIK3CA,CAB39,PSME1,VCL,EGFR
R-HSA-446203	Asparagine N-linked glycosylation	0.185027620592909	-1.68725016454581	181	7	0.033175355450237	211	8202	2517,10484,26503,85365,29926,7039,4121	FUCA1,SEC23A,SLC17A5,ALG2,GMPPA,TGFA,MAN1A1
R-HSA-5654736	Signaling by FGFR1	0.185460292371899	-1.68491447714252	314	11	0.0521327014218009	211	8202	3667,2254,817,4193,2905,2263,5290,5720,1026,7414,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-2428924	IGF1R signaling cascade	0.187523013597702	-1.67385370191577	281	10	0.0473933649289099	211	8202	3667,2254,817,2905,2263,5290,51719,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PIK3CA,CAB39,PSME1,VCL,EGFR
R-HSA-2428928	IRS-related events triggered by IGF1R	0.187523013597702	-1.67385370191577	281	10	0.0473933649289099	211	8202	3667,2254,817,2905,2263,5290,51719,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PIK3CA,CAB39,PSME1,VCL,EGFR
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.187523013597702	-1.67385370191577	281	10	0.0473933649289099	211	8202	3667,2254,817,2905,2263,5290,51719,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PIK3CA,CAB39,PSME1,VCL,EGFR
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.188269706418404	-1.66987973561146	8	1	0.004739336492891	211	8202	301	ANXA1
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.188269706418404	-1.66987973561146	8	1	0.004739336492891	211	8202	54894	RNF43
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.188269706418404	-1.66987973561146	8	1	0.004739336492891	211	8202	6513	SLC2A1
R-HSA-428643	Organic anion transporters	0.188269706418404	-1.66987973561146	8	1	0.004739336492891	211	8202	26503	SLC17A5
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.188269706418404	-1.66987973561146	8	1	0.004739336492891	211	8202	37	ACADVL
R-HSA-1483148	Synthesis of PG	0.188269706418404	-1.66987973561146	8	1	0.004739336492891	211	8202	8760	CDS2
R-HSA-2871796	FCERI mediated MAPK activation	0.188951784448774	-1.66626340520491	248	9	0.042654028436019	211	8202	3725,3667,2254,817,2263,2905,5720,7414,1956	JUN,IRS1,FGF9,CAMK2D,FGFR2,GRIN2C,PSME1,VCL,EGFR
R-HSA-2129379	Molecules associated with elastic fibres	0.189168058953173	-1.66511945821689	31	2	0.00947867298578199	211	8202	650,3685	BMP2,ITGAV
R-HSA-70263	Gluconeogenesis	0.189168058953173	-1.66511945821689	31	2	0.00947867298578199	211	8202	4190,6576	MDH1,SLC25A1
R-HSA-168638	NOD1/2 Signaling Pathway	0.189168058953173	-1.66511945821689	31	2	0.00947867298578199	211	8202	837,3656	CASP4,IRAK2
R-HSA-418990	Adherens junctions interactions	0.189168058953173	-1.66511945821689	31	2	0.00947867298578199	211	8202	81607,25945	PVRL4,PVRL3
R-HSA-156842	Eukaryotic Translation Elongation	0.19055296024293	-1.65782511652747	88	4	0.018957345971564	211	8202	6142,6170,6160,6235	RPL18A,RPL39,RPL31,RPS29
R-HSA-5654738	Signaling by FGFR2	0.190763240976358	-1.65672219588538	316	11	0.0521327014218009	211	8202	3667,2254,817,4193,2905,2263,5290,5720,1026,7414,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-2559580	Oxidative Stress Induced Senescence	0.191803713680063	-1.65128275446757	119	5	0.023696682464455	211	8202	1912,3725,23043,4193,23466	PHC2,JUN,TNIK,MDM2,CBX6
R-HSA-190236	Signaling by FGFR	0.193440696193892	-1.64278429310491	317	11	0.0521327014218009	211	8202	3667,2254,817,4193,2905,2263,5290,5720,1026,7414,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	0.19580936933204	-1.63061369848798	89	4	0.018957345971564	211	8202	6142,6170,6160,6235	RPL18A,RPL39,RPL31,RPS29
R-HSA-211945	Phase 1 - Functionalization of compounds	0.19580936933204	-1.63061369848798	89	4	0.018957345971564	211	8202	1591,8824,66002,2232	CYP24A1,CES2,CYP4F12,FDXR
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.19580936933204	-1.63061369848798	89	4	0.018957345971564	211	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-389356	CD28 co-stimulation	0.198567265235388	-1.616627368573	32	2	0.00947867298578199	211	8202	1326,5290	MAP3K8,PIK3CA
R-HSA-69615	G1/S DNA Damage Checkpoints	0.200157773693924	-1.60864935495767	60	3	0.014218009478673	211	8202	5720,4193,1026	PSME1,MDM2,CDKN1A
R-HSA-450294	MAP kinase activation in TLR cascade	0.200157773693924	-1.60864935495767	60	3	0.014218009478673	211	8202	3725,1326,3656	JUN,MAP3K8,IRAK2
R-HSA-1227986	Signaling by ERBB2	0.201574881015343	-1.6015943486861	320	11	0.0521327014218009	211	8202	3667,2254,817,4193,2905,2263,5290,5720,1026,7414,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.20333785918508	-1.59288635244332	355	12	0.0568720379146919	211	8202	3667,2254,817,4193,2905,2263,160,5290,5720,1026,7414,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,AP2A1,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.206817633906077	-1.57591786964431	61	3	0.014218009478673	211	8202	1591,66002,2232	CYP24A1,CYP4F12,FDXR
R-HSA-73847	Purine metabolism	0.208021470622421	-1.57011398046181	33	2	0.00947867298578199	211	8202	847,4907	CAT,NT5E
R-HSA-933541	TRAF6 mediated IRF7 activation	0.208021470622421	-1.57011398046181	33	2	0.00947867298578199	211	8202	10010,3659	TANK,IRF1
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.208021470622421	-1.57011398046181	33	2	0.00947867298578199	211	8202	672,197342	BRCA1,EME2
R-HSA-5694530	Cargo concentration in the ER	0.208021470622421	-1.57011398046181	33	2	0.00947867298578199	211	8202	10484,7039	SEC23A,TGFA
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.209172207261354	-1.56459740809623	9	1	0.004739336492891	211	8202	2232	FDXR
R-HSA-391908	Prostanoid ligand receptors	0.209172207261354	-1.56459740809623	9	1	0.004739336492891	211	8202	5734	PTGER4
R-HSA-196108	Pregnenolone biosynthesis	0.209172207261354	-1.56459740809623	9	1	0.004739336492891	211	8202	2232	FDXR
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.209172207261354	-1.56459740809623	9	1	0.004739336492891	211	8202	160	AP2A1
R-HSA-73614	Pyrimidine salvage reactions	0.209172207261354	-1.56459740809623	9	1	0.004739336492891	211	8202	1890	TYMP
R-HSA-2179392	EGFR Transactivation by Gastrin	0.209172207261354	-1.56459740809623	9	1	0.004739336492891	211	8202	1956	EGFR
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.211839170153568	-1.5519279235676	92	4	0.018957345971564	211	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.211839170153568	-1.5519279235676	92	4	0.018957345971564	211	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.211839170153568	-1.5519279235676	92	4	0.018957345971564	211	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.211839170153568	-1.5519279235676	92	4	0.018957345971564	211	8202	3725,1326,3656,1660	JUN,MAP3K8,IRAK2,DHX9
R-HSA-2424491	DAP12 signaling	0.215460251730806	-1.53497883317552	325	11	0.0521327014218009	211	8202	3667,2254,817,4193,2263,2905,5290,5720,1026,7414,1956	IRS1,FGF9,CAMK2D,MDM2,FGFR2,GRIN2C,PIK3CA,PSME1,CDKN1A,VCL,EGFR
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.217521679769307	-1.52545675632057	34	2	0.00947867298578199	211	8202	2254,2263	FGF9,FGFR2
R-HSA-1222556	ROS production in response to bacteria	0.217521679769307	-1.52545675632057	34	2	0.00947867298578199	211	8202	1535,523	CYBA,ATP6V1A
R-HSA-5693537	Resolution of D-Loop Structures	0.217521679769307	-1.52545675632057	34	2	0.00947867298578199	211	8202	672,197342	BRCA1,EME2
R-HSA-72689	Formation of a pool of free 40S subunits	0.222725741433315	-1.50181412346273	94	4	0.018957345971564	211	8202	6142,6170,6160,6235	RPL18A,RPL39,RPL31,RPS29
R-HSA-1236974	ER-Phagosome pathway	0.227082884238138	-1.48244019934166	64	3	0.014218009478673	211	8202	5720,6892,3107	PSME1,TAPBP,HLA-C
R-HSA-948021	Transport to the Golgi and subsequent modification	0.228223914194316	-1.47742805215293	95	4	0.018957345971564	211	8202	2517,10484,7039,4121	FUCA1,SEC23A,TGFA,MAN1A1
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.229538942798661	-1.47168257847926	10	1	0.004739336492891	211	8202	6628	SNRPB
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.229538942798661	-1.47168257847926	10	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-74749	Signal attenuation	0.229538942798661	-1.47168257847926	10	1	0.004739336492891	211	8202	3667	IRS1
R-HSA-419812	Calcitonin-like ligand receptors	0.229538942798661	-1.47168257847926	10	1	0.004739336492891	211	8202	133	ADM
R-HSA-2562578	TRIF-mediated programmed cell death	0.229538942798661	-1.47168257847926	10	1	0.004739336492891	211	8202	8737	RIPK1
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.229538942798661	-1.47168257847926	10	1	0.004739336492891	211	8202	3725	JUN
R-HSA-190377	FGFR2b ligand binding and activation	0.229538942798661	-1.47168257847926	10	1	0.004739336492891	211	8202	2263	FGFR2
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.229538942798661	-1.47168257847926	10	1	0.004739336492891	211	8202	3656	IRAK2
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.229538942798661	-1.47168257847926	10	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.229538942798661	-1.47168257847926	10	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-2161522	Abacavir transport and metabolism	0.229538942798661	-1.47168257847926	10	1	0.004739336492891	211	8202	5243	ABCB1
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.229538942798661	-1.47168257847926	10	1	0.004739336492891	211	8202	3656	IRAK2
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.233461375057022	-1.45473863287082	228	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.233461375057022	-1.45473863287082	228	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-180336	SHC1 events in EGFR signaling	0.233461375057022	-1.45473863287082	228	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-5673001	RAF/MAP kinase cascade	0.233461375057022	-1.45473863287082	228	8	0.037914691943128	211	8202	3667,2254,817,2263,2905,5720,7414,1956	IRS1,FGF9,CAMK2D,FGFR2,GRIN2C,PSME1,VCL,EGFR
R-HSA-179812	GRB2 events in EGFR signaling	0.233461375057022	-1.45473863287082	228	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-112412	SOS-mediated signalling	0.233461375057022	-1.45473863287082	228	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.233461375057022	-1.45473863287082	228	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-202424	Downstream TCR signaling	0.23375640981013	-1.45347568954169	96	4	0.018957345971564	211	8202	5588,5720,3635,5290	PRKCQ,PSME1,INPP5D,PIK3CA
R-HSA-397014	Muscle contraction	0.233922201945927	-1.4527666892215	65	3	0.014218009478673	211	8202	7431,7414,301	VIM,VCL,ANXA1
R-HSA-196071	Metabolism of steroid hormones and vitamin D	0.236626223819553	-1.44127349748693	36	2	0.00947867298578199	211	8202	1591,2232	CYP24A1,FDXR
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.236990677792385	-1.43973447282996	229	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.236990677792385	-1.43973447282996	229	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.236990677792385	-1.43973447282996	229	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.236990677792385	-1.43973447282996	229	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.240798262417256	-1.42379578144869	66	3	0.014218009478673	211	8202	8737,23220,1660	RIPK1,DTX4,DHX9
R-HSA-2187338	Visual phototransduction	0.244917600732066	-1.40683344854944	98	4	0.018957345971564	211	8202	26020,5588,9249,157506	LRP10,PRKCQ,DHRS3,RDH10
R-HSA-375165	NCAM signaling for neurite out-growth	0.246207934336541	-1.40157883855147	266	9	0.042654028436019	211	8202	3667,2254,817,2905,2263,1291,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,COL6A1,PSME1,VCL,EGFR
R-HSA-438064	Post NMDA receptor activation events	0.246214617667503	-1.40155169385253	37	2	0.00947867298578199	211	8202	817,2905	CAMK2D,GRIN2C
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	0.246214617667503	-1.40155169385253	37	2	0.00947867298578199	211	8202	6118,672	RPA2,BRCA1
R-HSA-170984	ARMS-mediated activation	0.247688522081265	-1.39558328154486	232	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-187706	Signalling to p38 via RIT and RIN	0.247688522081265	-1.39558328154486	232	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-216083	Integrin cell surface interactions	0.24770791721679	-1.39550498007155	67	3	0.014218009478673	211	8202	3685,3675,960	ITGAV,ITGA3,CD44
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.24770791721679	-1.39550498007155	67	3	0.014218009478673	211	8202	26503,85365,29926	SLC17A5,ALG2,GMPPA
R-HSA-1500931	Cell-Cell communication	0.247732963461994	-1.39540387317382	131	5	0.023696682464455	211	8202	81607,1308,3691,25945,5290	PVRL4,COL17A1,ITGB4,PVRL3,PIK3CA
R-HSA-879518	Transport of organic anions	0.24938358184791	-1.38876307850493	11	1	0.004739336492891	211	8202	28232	SLCO3A1
R-HSA-2022923	Dermatan sulfate biosynthesis	0.24938358184791	-1.38876307850493	11	1	0.004739336492891	211	8202	1462	VCAN
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.24938358184791	-1.38876307850493	11	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-3371378	Regulation by c-FLIP	0.24938358184791	-1.38876307850493	11	1	0.004739336492891	211	8202	8737	RIPK1
R-HSA-1980148	Signaling by NOTCH3	0.24938358184791	-1.38876307850493	11	1	0.004739336492891	211	8202	182	JAG1
R-HSA-5218900	CASP8 activity is inhibited	0.24938358184791	-1.38876307850493	11	1	0.004739336492891	211	8202	8737	RIPK1
R-HSA-1059683	Interleukin-6 signaling	0.24938358184791	-1.38876307850493	11	1	0.004739336492891	211	8202	6772	STAT1
R-HSA-1236977	Endosomal/Vacuolar pathway	0.24938358184791	-1.38876307850493	11	1	0.004739336492891	211	8202	3107	HLA-C
R-HSA-5655291	Signaling by FGFR4 in disease	0.24938358184791	-1.38876307850493	11	1	0.004739336492891	211	8202	5290	PIK3CA
R-HSA-69416	Dimerization of procaspase-8	0.24938358184791	-1.38876307850493	11	1	0.004739336492891	211	8202	8737	RIPK1
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.24938358184791	-1.38876307850493	11	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-189451	Heme biosynthesis	0.24938358184791	-1.38876307850493	11	1	0.004739336492891	211	8202	7390	UROS
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.24938358184791	-1.38876307850493	11	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.24938358184791	-1.38876307850493	11	1	0.004739336492891	211	8202	1535	CYBA
R-HSA-1980150	Signaling by NOTCH4	0.24938358184791	-1.38876307850493	11	1	0.004739336492891	211	8202	182	JAG1
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.24938358184791	-1.38876307850493	11	1	0.004739336492891	211	8202	6628	SNRPB
R-HSA-170968	Frs2-mediated activation	0.251289764024928	-1.38114856735557	233	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-75109	Triglyceride Biosynthesis	0.254648071055794	-1.36787280056419	68	3	0.014218009478673	211	8202	51495,84803,6576	HACD3,GPAT3,SLC25A1
R-HSA-5684996	MAPK1/MAPK3 signaling	0.254907970447407	-1.36685269917011	234	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-169893	Prolonged ERK activation events	0.258542728234279	-1.3526943057171	235	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.261874721310905	-1.33988905251287	101	4	0.018957345971564	211	8202	30061,204962,6513,9123	SLC40A1,SLC44A5,SLC2A1,SLC16A3
R-HSA-2586552	Signaling by Leptin	0.262193622038782	-1.33867203274327	236	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.265426646437818	-1.32641676107709	39	2	0.00947867298578199	211	8202	6118,672	RPA2,BRCA1
R-HSA-453279	Mitotic G1-G1/S phases	0.267262996454779	-1.31952209993282	135	5	0.023696682464455	211	8202	7153,6118,5720,1026,891	TOP2A,RPA2,PSME1,CDKN1A,CCNB1
R-HSA-69473	G2/M DNA damage checkpoint	0.268607769320212	-1.31450307006854	70	3	0.014218009478673	211	8202	672,891,2810	BRCA1,CCNB1,SFN
R-HSA-2160916	Hyaluronan uptake and degradation	0.268719446120854	-1.31408739485597	12	1	0.004739336492891	211	8202	960	CD44
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.268719446120854	-1.31408739485597	12	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-3371511	HSF1 activation	0.268719446120854	-1.31408739485597	12	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.268719446120854	-1.31408739485597	12	1	0.004739336492891	211	8202	8737	RIPK1
R-HSA-190373	FGFR1c ligand binding and activation	0.268719446120854	-1.31408739485597	12	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-174414	Processive synthesis on the C-strand of the telomere	0.268719446120854	-1.31408739485597	12	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-190239	FGFR3 ligand binding and activation	0.268719446120854	-1.31408739485597	12	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-2033514	FGFR3 mutant receptor activation	0.268719446120854	-1.31408739485597	12	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-211979	Eicosanoids	0.268719446120854	-1.31408739485597	12	1	0.004739336492891	211	8202	66002	CYP4F12
R-HSA-190372	FGFR3c ligand binding and activation	0.268719446120854	-1.31408739485597	12	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-432047	Passive transport by Aquaporins	0.268719446120854	-1.31408739485597	12	1	0.004739336492891	211	8202	360	AQP3
R-HSA-1280218	Adaptive Immune System	0.27015108471946	-1.30877390345133	668	20	0.0947867298578199	211	8202	10484,2254,3635,1326,5588,5720,1026,1956,3667,6892,4193,1535,2263,160,5290,51434,3685,79659,3107,64167	SEC23A,FGF9,INPP5D,MAP3K8,PRKCQ,PSME1,CDKN1A,EGFR,IRS1,TAPBP,MDM2,CYBA,FGFR2,AP2A1,PIK3CA,ANAPC7,ITGAV,DYNC2H1,HLA-C,ERAP2
R-HSA-168255	Influenza Life Cycle	0.272199965846901	-1.30121831423539	136	5	0.023696682464455	211	8202	6142,6170,6160,6235,3304	RPL18A,RPL39,RPL31,RPS29,HSPA1B
R-HSA-167044	Signalling to RAS	0.27323893620475	-1.29740864238931	239	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-5696400	Dual Incision in GG-NER	0.275036561165209	-1.29085124046092	40	2	0.00947867298578199	211	8202	6118,1643	RPA2,DDB2
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.275036561165209	-1.29085124046092	40	2	0.00947867298578199	211	8202	2495,10808	FTH1,HSPH1
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	0.279050547164903	-1.27636234093649	104	4	0.018957345971564	211	8202	6142,6170,6160,6235	RPL18A,RPL39,RPL31,RPS29
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.280675459154952	-1.2705562267432	241	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.282653710371586	-1.26353276885842	72	3	0.014218009478673	211	8202	51434,5720,891	ANAPC7,PSME1,CCNB1
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.284640498338813	-1.25652830429741	41	2	0.00947867298578199	211	8202	817,2905	CAMK2D,GRIN2C
R-HSA-5620924	Intraflagellar transport	0.284640498338813	-1.25652830429741	41	2	0.00947867298578199	211	8202	79659,56912	DYNC2H1,IFT46
R-HSA-69481	G2/M Checkpoints	0.28481683683706	-1.25590898308407	105	4	0.018957345971564	211	8202	6118,672,891,2810	RPA2,BRCA1,CCNB1,SFN
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	0.28481683683706	-1.25590898308407	105	4	0.018957345971564	211	8202	6142,6170,6160,6235	RPL18A,RPL39,RPL31,RPS29
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	51	ACOX1
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	51	ACOX1
R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	8737	RIPK1
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	6513	SLC2A1
R-HSA-75205	Dissolution of Fibrin Clot	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	6281	S100A10
R-HSA-3270619	IRF3-mediated induction of type I IFN	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	23220	DTX4
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	1660	DHX9
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	4000	LMNA
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	160	AP2A1
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	8821	INPP4B
R-HSA-2995410	Nuclear Envelope Reassembly	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	4000	LMNA
R-HSA-5626467	RHO GTPases activate IQGAPs	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	10788	IQGAP2
R-HSA-4641265	Repression of WNT target genes	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	7088	TLE1
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	64428	NARFL
R-HSA-1483213	Synthesis of PE	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	1119	CHKA
R-HSA-177504	Retrograde neurotrophin signalling	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	160	AP2A1
R-HSA-1663150	The activation of arylsulfatases	0.287559518999352	-1.24632541756451	13	1	0.004739336492891	211	8202	79642	ARSJ
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.289701885514671	-1.23890286572035	73	3	0.014218009478673	211	8202	51434,5720,891	ANAPC7,PSME1,CCNB1
R-HSA-927802	Nonsense-Mediated Decay (NMD)	0.290600972177964	-1.23580418243529	106	4	0.018957345971564	211	8202	6142,6170,6160,6235	RPL18A,RPL39,RPL31,RPS29
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	0.290600972177964	-1.23580418243529	106	4	0.018957345971564	211	8202	6142,6170,6160,6235	RPL18A,RPL39,RPL31,RPS29
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.294232432065718	-1.22338523873382	42	2	0.00947867298578199	211	8202	7088,6662	TLE1,SOX9
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.294232432065718	-1.22338523873382	42	2	0.00947867298578199	211	8202	6118,672	RPA2,BRCA1
R-HSA-1566948	Elastic fibre formation	0.294232432065718	-1.22338523873382	42	2	0.00947867298578199	211	8202	650,3685	BMP2,ITGAV
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.294232432065718	-1.22338523873382	42	2	0.00947867298578199	211	8202	85441,8204	HELZ2,NRIP1
R-HSA-112315	Transmission across Chemical Synapses	0.296175214525354	-1.21680405882199	210	7	0.033175355450237	211	8202	54331,817,4193,2905,10550,160,6505	GNG2,CAMK2D,MDM2,GRIN2C,ARL6IP5,AP2A1,SLC1A1
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.29635543913449	-1.21619573716443	424	13	0.0616113744075829	211	8202	54331,3667,2254,817,2905,2263,5290,5720,5588,5997,7414,1956,301	GNG2,IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PIK3CA,PSME1,PRKCQ,RGS2,VCL,EGFR,ANXA1
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	0.296401380191697	-1.21604072905385	107	4	0.018957345971564	211	8202	6142,6170,6160,6235	RPL18A,RPL39,RPL31,RPS29
R-HSA-187687	Signalling to ERKs	0.299497397172434	-1.20564955204058	246	8	0.037914691943128	211	8202	3667,2254,817,2905,2263,5720,7414,1956	IRS1,FGF9,CAMK2D,GRIN2C,FGFR2,PSME1,VCL,EGFR
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.302199247474629	-1.19666871930335	142	5	0.023696682464455	211	8202	54331,817,4193,2905,160	GNG2,CAMK2D,MDM2,GRIN2C,AP2A1
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.30380664754847	-1.19136380772849	43	2	0.00947867298578199	211	8202	54331,360	GNG2,AQP3
R-HSA-1221632	Meiotic synapsis	0.303834891968881	-1.19127084364162	75	3	0.014218009478673	211	8202	672,23224,4000	BRCA1,SYNE2,LMNA
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.305916454087167	-1.18444324016703	14	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.305916454087167	-1.18444324016703	14	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-2024101	CS/DS degradation	0.305916454087167	-1.18444324016703	14	1	0.004739336492891	211	8202	1462	VCAN
R-HSA-69166	Removal of the Flap Intermediate	0.305916454087167	-1.18444324016703	14	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.305916454087167	-1.18444324016703	14	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-190322	FGFR4 ligand binding and activation	0.305916454087167	-1.18444324016703	14	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.305916454087167	-1.18444324016703	14	1	0.004739336492891	211	8202	10371	SEMA3A
R-HSA-5675482	Regulation of necroptotic cell death	0.305916454087167	-1.18444324016703	14	1	0.004739336492891	211	8202	8737	RIPK1
R-HSA-877312	Regulation of IFNG signaling	0.305916454087167	-1.18444324016703	14	1	0.004739336492891	211	8202	6772	STAT1
R-HSA-69206	G1/S Transition	0.308044807962271	-1.17751002619282	109	4	0.018957345971564	211	8202	6118,5720,1026,891	RPA2,PSME1,CDKN1A,CCNB1
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.313357729211866	-1.16040983623026	44	2	0.00947867298578199	211	8202	6118,1643	RPA2,DDB2
R-HSA-446652	Interleukin-1 signaling	0.313357729211866	-1.16040983623026	44	2	0.00947867298578199	211	8202	1326,3656	MAP3K8,IRAK2
R-HSA-166520	Signalling by NGF	0.313788840684129	-1.15903500118894	430	13	0.0616113744075829	211	8202	3667,2254,817,4193,2905,2263,160,5290,5720,1026,7414,7074,1956	IRS1,FGF9,CAMK2D,MDM2,GRIN2C,FGFR2,AP2A1,PIK3CA,PSME1,CDKN1A,VCL,TIAM1,EGFR
R-HSA-70326	Glucose metabolism	0.317999142050131	-1.14570659416116	77	3	0.014218009478673	211	8202	4190,5236,6576	MDH1,PGM1,SLC25A1
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.317999142050131	-1.14570659416116	77	3	0.014218009478673	211	8202	51434,5720,891	ANAPC7,PSME1,CCNB1
R-HSA-3322077	Glycogen synthesis	0.323802583568282	-1.12762125886901	15	1	0.004739336492891	211	8202	5236	PGM1
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.323802583568282	-1.12762125886901	15	1	0.004739336492891	211	8202	196513	DCP1B
R-HSA-211935	Fatty acids	0.323802583568282	-1.12762125886901	15	1	0.004739336492891	211	8202	66002	CYP4F12
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.323802583568282	-1.12762125886901	15	1	0.004739336492891	211	8202	23220	DTX4
R-HSA-391903	Eicosanoid ligand-binding receptors	0.323802583568282	-1.12762125886901	15	1	0.004739336492891	211	8202	5734	PTGER4
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.323802583568282	-1.12762125886901	15	1	0.004739336492891	211	8202	2810	SFN
R-HSA-159418	Recycling of bile acids and salts	0.323802583568282	-1.12762125886901	15	1	0.004739336492891	211	8202	8714	ABCC3
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.323802583568282	-1.12762125886901	15	1	0.004739336492891	211	8202	9564	BCAR1
R-HSA-5358508	Mismatch Repair	0.323802583568282	-1.12762125886901	15	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.323802583568282	-1.12762125886901	15	1	0.004739336492891	211	8202	160	AP2A1
R-HSA-418346	Platelet homeostasis	0.325086601286099	-1.12366366665233	78	3	0.014218009478673	211	8202	54331,10846,5139	GNG2,PDE10A,PDE3A
R-HSA-72737	Cap-dependent Translation Initiation	0.325593684717315	-1.1221050408732	112	4	0.018957345971564	211	8202	6142,6170,6160,6235	RPL18A,RPL39,RPL31,RPS29
R-HSA-72613	Eukaryotic Translation Initiation	0.325593684717315	-1.1221050408732	112	4	0.018957345971564	211	8202	6142,6170,6160,6235	RPL18A,RPL39,RPL31,RPS29
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.332370256327409	-1.10150570157072	46	2	0.00947867298578199	211	8202	51495,6576	HACD3,SLC25A1
R-HSA-418597	G alpha (z) signalling events	0.332370256327409	-1.10150570157072	46	2	0.00947867298578199	211	8202	54331,5588	GNG2,PRKCQ
R-HSA-168256	Immune System	0.33249650915296	-1.10112591772943	1371	38	0.180094786729858	211	8202	523,3635,1326,1660,8737,5720,1026,3725,4193,2905,10010,5290,51434,3107,4940,79659,960,7414,64167,2254,10484,5588,26999,837,9636,1956,6773,3667,817,6892,1535,2263,160,3656,6772,23220,3685,3659	ATP6V1A,INPP5D,MAP3K8,DHX9,RIPK1,PSME1,CDKN1A,JUN,MDM2,GRIN2C,TANK,PIK3CA,ANAPC7,HLA-C,OAS3,DYNC2H1,CD44,VCL,ERAP2,FGF9,SEC23A,PRKCQ,CYFIP2,CASP4,ISG15,EGFR,STAT2,IRS1,CAMK2D,TAPBP,CYBA,FGFR2,AP2A1,IRAK2,STAT1,DTX4,ITGAV,IRF1
R-HSA-110312	Translesion synthesis by REV1	0.341229926287461	-1.07519875827922	16	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.341229926287461	-1.07519875827922	16	1	0.004739336492891	211	8202	1326	MAP3K8
R-HSA-399956	CRMPs in Sema3A signaling	0.341229926287461	-1.07519875827922	16	1	0.004739336492891	211	8202	10371	SEMA3A
R-HSA-156711	Polo-like kinase mediated events	0.341229926287461	-1.07519875827922	16	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.341229926287461	-1.07519875827922	16	1	0.004739336492891	211	8202	3656	IRAK2
R-HSA-5218859	Regulated Necrosis	0.341229926287461	-1.07519875827922	16	1	0.004739336492891	211	8202	8737	RIPK1
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.341229926287461	-1.07519875827922	16	1	0.004739336492891	211	8202	136	ADORA2B
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.341229926287461	-1.07519875827922	16	1	0.004739336492891	211	8202	516	ATP5G1
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.341229926287461	-1.07519875827922	16	1	0.004739336492891	211	8202	10371	SEMA3A
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.341229926287461	-1.07519875827922	16	1	0.004739336492891	211	8202	160	AP2A1
R-HSA-1834941	STING mediated induction of host immune responses	0.341229926287461	-1.07519875827922	16	1	0.004739336492891	211	8202	23220	DTX4
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.341229926287461	-1.07519875827922	16	1	0.004739336492891	211	8202	8737	RIPK1
R-HSA-69183	Processive synthesis on the lagging strand	0.341229926287461	-1.07519875827922	16	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-190242	FGFR1 ligand binding and activation	0.341229926287461	-1.07519875827922	16	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-1369062	ABC transporters in lipid homeostasis	0.341229926287461	-1.07519875827922	16	1	0.004739336492891	211	8202	5825	ABCD3
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.341822265244289	-1.07346436927452	47	2	0.00947867298578199	211	8202	837,3656	CASP4,IRAK2
R-HSA-202403	TCR signaling	0.343207624595865	-1.06941969542669	115	4	0.018957345971564	211	8202	5588,5720,3635,5290	PRKCQ,PSME1,INPP5D,PIK3CA
R-HSA-1500620	Meiosis	0.343207624595865	-1.06941969542669	115	4	0.018957345971564	211	8202	6118,672,23224,4000	RPA2,BRCA1,SYNE2,LMNA
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.351232246191036	-1.04630760426346	48	2	0.00947867298578199	211	8202	54331,5290	GNG2,PIK3CA
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.358210195729752	-1.02663532597013	17	1	0.004739336492891	211	8202	51434	ANAPC7
R-HSA-5656121	Translesion synthesis by POLI	0.358210195729752	-1.02663532597013	17	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-5655862	Translesion synthesis by POLK	0.358210195729752	-1.02663532597013	17	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.358210195729752	-1.02663532597013	17	1	0.004739336492891	211	8202	3656	IRAK2
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.358210195729752	-1.02663532597013	17	1	0.004739336492891	211	8202	677	ZFP36L1
R-HSA-140534	Ligand-dependent caspase activation	0.358210195729752	-1.02663532597013	17	1	0.004739336492891	211	8202	8737	RIPK1
R-HSA-5627117	RHO GTPases Activate ROCKs	0.358210195729752	-1.02663532597013	17	1	0.004739336492891	211	8202	9475	ROCK2
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	0.358210195729752	-1.02663532597013	17	1	0.004739336492891	211	8202	7941	PLA2G7
R-HSA-1482801	Acyl chain remodelling of PS	0.358210195729752	-1.02663532597013	17	1	0.004739336492891	211	8202	10162	LPCAT3
R-HSA-189445	Metabolism of porphyrins	0.358210195729752	-1.02663532597013	17	1	0.004739336492891	211	8202	7390	UROS
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.358210195729752	-1.02663532597013	17	1	0.004739336492891	211	8202	37	ACADVL
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.358210195729752	-1.02663532597013	17	1	0.004739336492891	211	8202	5236	PGM1
R-HSA-453276	Regulation of mitotic cell cycle	0.360481292618161	-1.02031521647973	83	3	0.014218009478673	211	8202	51434,5720,891	ANAPC7,PSME1,CCNB1
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.360481292618161	-1.02031521647973	83	3	0.014218009478673	211	8202	51434,5720,891	ANAPC7,PSME1,CCNB1
R-HSA-425407	SLC-mediated transmembrane transport	0.369244877437351	-0.996295230551505	264	8	0.037914691943128	211	8202	30061,6513,65010,9123,26503,6505,28232,204962	SLC40A1,SLC2A1,SLC26A6,SLC16A3,SLC17A5,SLC1A1,SLCO3A1,SLC44A5
R-HSA-2980766	Nuclear Envelope Breakdown	0.369910023170205	-0.994495483538137	50	2	0.00947867298578199	211	8202	891,4000	CCNB1,LMNA
R-HSA-429914	Deadenylation-dependent mRNA decay	0.369910023170205	-0.994495483538137	50	2	0.00947867298578199	211	8202	85456,196513	TNKS1BP1,DCP1B
R-HSA-112310	Neurotransmitter Release Cycle	0.369910023170205	-0.994495483538137	50	2	0.00947867298578199	211	8202	10550,6505	ARL6IP5,SLC1A1
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.374754807658159	-0.981483313107313	18	1	0.004739336492891	211	8202	10010	TANK
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.374754807658159	-0.981483313107313	18	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.374754807658159	-0.981483313107313	18	1	0.004739336492891	211	8202	51434	ANAPC7
R-HSA-912631	Regulation of signaling by CBL	0.374754807658159	-0.981483313107313	18	1	0.004739336492891	211	8202	5290	PIK3CA
R-HSA-156584	Cytosolic sulfonation of small molecules	0.374754807658159	-0.981483313107313	18	1	0.004739336492891	211	8202	6819	SULT1C2
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.374754807658159	-0.981483313107313	18	1	0.004739336492891	211	8202	112399	EGLN3
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.374754807658159	-0.981483313107313	18	1	0.004739336492891	211	8202	51434	ANAPC7
R-HSA-210993	Tie2 Signaling	0.374754807658159	-0.981483313107313	18	1	0.004739336492891	211	8202	5290	PIK3CA
R-HSA-383280	Nuclear Receptor transcription pathway	0.37917034903558	-0.96976970513011	51	2	0.00947867298578199	211	8202	5468,7025	PPARG,NR2F1
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.37917034903558	-0.96976970513011	51	2	0.00947867298578199	211	8202	1462,79586	VCAN,CHPF
R-HSA-445717	Aquaporin-mediated transport	0.37917034903558	-0.96976970513011	51	2	0.00947867298578199	211	8202	54331,360	GNG2,AQP3
R-HSA-397795	G-protein beta:gamma signalling	0.37917034903558	-0.96976970513011	51	2	0.00947867298578199	211	8202	54331,5290	GNG2,PIK3CA
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.37917034903558	-0.96976970513011	51	2	0.00947867298578199	211	8202	2254,2263	FGF9,FGFR2
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.381055686670586	-0.964809755295273	267	8	0.037914691943128	211	8202	10484,6892,1535,5720,51434,3685,3107,64167	SEC23A,TAPBP,CYBA,PSME1,ANAPC7,ITGAV,HLA-C,ERAP2
R-HSA-1474290	Collagen formation	0.381603779597287	-0.963372434852007	86	3	0.014218009478673	211	8202	1308,3691,1291	COL17A1,ITGB4,COL6A1
R-HSA-381119	Unfolded Protein Response (UPR)	0.381603779597287	-0.963372434852007	86	3	0.014218009478673	211	8202	37,4189,4000	ACADVL,DNAJB9,LMNA
R-HSA-211859	Biological oxidations	0.382299231657366	-0.961551648071572	194	6	0.028436018957346	211	8202	1591,2941,6819,8824,66002,2232	CYP24A1,GSTA4,SULT1C2,CES2,CYP4F12,FDXR
R-HSA-69541	Stabilization of p53	0.388373688282572	-0.945787288725361	52	2	0.00947867298578199	211	8202	5720,4193	PSME1,MDM2
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.388373688282572	-0.945787288725361	52	2	0.00947867298578199	211	8202	26503,29926	SLC17A5,GMPPA
R-HSA-373080	Class B/2 (Secretin family receptors)	0.388613099271997	-0.945171033723766	87	3	0.014218009478673	211	8202	54331,51384,133	GNG2,WNT16,ADM
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.388613099271997	-0.945171033723766	87	3	0.014218009478673	211	8202	677,5720,3304	ZFP36L1,PSME1,HSPA1B
R-HSA-3000480	Scavenging by Class A Receptors	0.390874887757497	-0.9393677503612	19	1	0.004739336492891	211	8202	2495	FTH1
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.390874887757497	-0.9393677503612	19	1	0.004739336492891	211	8202	1462	VCAN
R-HSA-69618	Mitotic Spindle Checkpoint	0.390874887757497	-0.9393677503612	19	1	0.004739336492891	211	8202	51434	ANAPC7
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.390874887757497	-0.9393677503612	19	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.390874887757497	-0.9393677503612	19	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.390874887757497	-0.9393677503612	19	1	0.004739336492891	211	8202	1462	VCAN
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.390874887757497	-0.9393677503612	19	1	0.004739336492891	211	8202	1462	VCAN
R-HSA-5687128	MAPK6/MAPK4 signaling	0.395603457116728	-0.927342940351825	88	3	0.014218009478673	211	8202	3725,5720,3337	JUN,PSME1,DNAJB1
R-HSA-194840	Rho GTPase cycle	0.396065750973289	-0.926175043699071	124	4	0.018957345971564	211	8202	58480,54509,7074,23526	RHOU,RHOF,TIAM1,HMHA1
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.397516845468892	-0.922517967247603	53	2	0.00947867298578199	211	8202	5720,60489	PSME1,APOBEC3G
R-HSA-2028269	Signaling by Hippo	0.406581278894719	-0.899971421900735	20	1	0.004739336492891	211	8202	154796	AMOT
R-HSA-418217	G beta:gamma signalling through PLC beta	0.406581278894719	-0.899971421900735	20	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-4641257	Degradation of AXIN	0.406596825563572	-0.899933185089464	54	2	0.00947867298578199	211	8202	5720,8313	PSME1,AXIN2
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.406596825563572	-0.899933185089464	54	2	0.00947867298578199	211	8202	3691,1291	ITGB4,COL6A1
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.413575085578502	-0.882916195565299	127	4	0.018957345971564	211	8202	6142,6170,6160,6235	RPL18A,RPL39,RPL31,RPS29
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.41561082586752	-0.878005971329436	55	2	0.00947867298578199	211	8202	5720,3304	PSME1,HSPA1B
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.421884548302957	-0.863023584597048	21	1	0.004739336492891	211	8202	160	AP2A1
R-HSA-500657	Presynaptic function of Kainate receptors	0.421884548302957	-0.863023584597048	21	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-5654688	SHC-mediated cascade:FGFR1	0.421884548302957	-0.863023584597048	21	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-4641263	Regulation of FZD by ubiquitination	0.421884548302957	-0.863023584597048	21	1	0.004739336492891	211	8202	54894	RNF43
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	0.421884548302957	-0.863023584597048	21	1	0.004739336492891	211	8202	3489	IGFBP6
R-HSA-390918	Peroxisomal lipid metabolism	0.421884548302957	-0.863023584597048	21	1	0.004739336492891	211	8202	51	ACOX1
R-HSA-69186	Lagging Strand Synthesis	0.421884548302957	-0.863023584597048	21	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.421884548302957	-0.863023584597048	21	1	0.004739336492891	211	8202	50484	RRM2B
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.424556228158546	-0.856710824620705	56	2	0.00947867298578199	211	8202	5720,1026	PSME1,CDKN1A
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.425189829336048	-0.855219552518093	129	4	0.018957345971564	211	8202	6118,672,5429,197342	RPA2,BRCA1,POLH,EME2
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.436794994487421	-0.828291314123923	22	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.436794994487421	-0.828291314123923	22	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.436794994487421	-0.828291314123923	22	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.436794994487421	-0.828291314123923	22	1	0.004739336492891	211	8202	157506	RDH10
R-HSA-373753	Nephrin interactions	0.436794994487421	-0.828291314123923	22	1	0.004739336492891	211	8202	5290	PIK3CA
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.436794994487421	-0.828291314123923	22	1	0.004739336492891	211	8202	2517	FUCA1
R-HSA-382551	Transmembrane transport of small molecules	0.43984698315929	-0.82132837810136	586	16	0.0758293838862559	211	8202	30061,523,6513,65010,9123,2495,360,26503,28232,6505,54331,5825,5243,6446,8714,204962	SLC40A1,ATP6V1A,SLC2A1,SLC26A6,SLC16A3,FTH1,AQP3,SLC17A5,SLCO3A1,SLC1A1,GNG2,ABCD3,ABCB1,SGK1,ABCC3,SLC44A5
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.450635729144285	-0.797095961752223	96	3	0.014218009478673	211	8202	26503,6505,65010	SLC17A5,SLC1A1,SLC26A6
R-HSA-73980	RNA Polymerase III Transcription Termination	0.451322654161717	-0.795572775842635	23	1	0.004739336492891	211	8202	4781	NFIB
R-HSA-429947	Deadenylation of mRNA	0.451322654161717	-0.795572775842635	23	1	0.004739336492891	211	8202	85456	TNKS1BP1
R-HSA-1482839	Acyl chain remodelling of PE	0.451322654161717	-0.795572775842635	23	1	0.004739336492891	211	8202	10162	LPCAT3
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.451322654161717	-0.795572775842635	23	1	0.004739336492891	211	8202	7050	TGIF1
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.451322654161717	-0.795572775842635	23	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.451322654161717	-0.795572775842635	23	1	0.004739336492891	211	8202	51434	ANAPC7
R-HSA-428930	Thromboxane signalling through TP receptor	0.451322654161717	-0.795572775842635	23	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.451322654161717	-0.795572775842635	23	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.451322654161717	-0.795572775842635	23	1	0.004739336492891	211	8202	6628	SNRPB
R-HSA-211976	Endogenous sterols	0.451322654161717	-0.795572775842635	23	1	0.004739336492891	211	8202	2232	FDXR
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.451322654161717	-0.795572775842635	23	1	0.004739336492891	211	8202	4048	LTA4H
R-HSA-201451	Signaling by BMP	0.451322654161717	-0.795572775842635	23	1	0.004739336492891	211	8202	650	BMP2
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.451322654161717	-0.795572775842635	23	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.459605533788813	-0.777386692634388	60	2	0.00947867298578199	211	8202	51434,5720	ANAPC7,PSME1
R-HSA-5693538	Homology Directed Repair	0.459661702173331	-0.777264490118318	135	4	0.018957345971564	211	8202	6118,672,5429,197342	RPA2,BRCA1,POLH,EME2
R-HSA-195721	Signaling by Wnt	0.462950123329886	-0.770135955688102	326	9	0.042654028436019	211	8202	54331,79971,160,6662,8313,7088,5720,54894,51384	GNG2,WLS,AP2A1,SOX9,AXIN2,TLE1,PSME1,RNF43,WNT16
R-HSA-69239	Synthesis of DNA	0.464089131783702	-0.767678650842214	98	3	0.014218009478673	211	8202	6118,5720,1026	RPA2,PSME1,CDKN1A
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.465477308758664	-0.764691929406598	24	1	0.004739336492891	211	8202	9475	ROCK2
R-HSA-70268	Pyruvate metabolism	0.465477308758664	-0.764691929406598	24	1	0.004739336492891	211	8202	9123	SLC16A3
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.465477308758664	-0.764691929406598	24	1	0.004739336492891	211	8202	8737	RIPK1
R-HSA-933542	TRAF6 mediated NF-kB activation	0.465477308758664	-0.764691929406598	24	1	0.004739336492891	211	8202	1660	DHX9
R-HSA-421270	Cell-cell junction organization	0.468174615141056	-0.758913943376687	61	2	0.00947867298578199	211	8202	81607,25945	PVRL4,PVRL3
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.479268490945007	-0.735494314712518	25	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-1296059	G protein gated Potassium channels	0.479268490945007	-0.735494314712518	25	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-114452	Activation of BH3-only proteins	0.479268490945007	-0.735494314712518	25	1	0.004739336492891	211	8202	2810	SFN
R-HSA-1482788	Acyl chain remodelling of PC	0.479268490945007	-0.735494314712518	25	1	0.004739336492891	211	8202	10162	LPCAT3
R-HSA-1538133	G0 and Early G1	0.479268490945007	-0.735494314712518	25	1	0.004739336492891	211	8202	7153	TOP2A
R-HSA-425410	Metal ion SLC transporters	0.479268490945007	-0.735494314712518	25	1	0.004739336492891	211	8202	30061	SLC40A1
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.479268490945007	-0.735494314712518	25	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-2262749	Cellular response to hypoxia	0.479268490945007	-0.735494314712518	25	1	0.004739336492891	211	8202	112399	EGLN3
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.479268490945007	-0.735494314712518	25	1	0.004739336492891	211	8202	51495	HACD3
R-HSA-1296041	Activation of G protein gated Potassium channels	0.479268490945007	-0.735494314712518	25	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.479268490945007	-0.735494314712518	25	1	0.004739336492891	211	8202	112399	EGLN3
R-HSA-400253	Circadian Clock	0.485068738375513	-0.7234646694779	63	2	0.00947867298578199	211	8202	85441,8204	HELZ2,NRIP1
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.490554329324593	-0.712219242961487	102	3	0.014218009478673	211	8202	516,4719,7385	ATP5G1,NDUFS1,UQCRC2
R-HSA-2132295	MHC class II antigen presentation	0.490554329324593	-0.712219242961487	102	3	0.014218009478673	211	8202	10484,79659,160	SEC23A,DYNC2H1,AP2A1
R-HSA-597592	Post-translational protein modification	0.490959468364722	-0.711393703750338	411	11	0.0521327014218009	211	8202	1912,2517,10484,10678,7039,85365,672,26503,79642,29926,4121	PHC2,FUCA1,SEC23A,B3GNT2,TGFA,ALG2,BRCA1,SLC17A5,ARSJ,GMPPA,MAN1A1
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.492705490869805	-0.707843665045759	26	1	0.004739336492891	211	8202	1462	VCAN
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.492705490869805	-0.707843665045759	26	1	0.004739336492891	211	8202	672	BRCA1
R-HSA-3781865	Diseases of glycosylation	0.492705490869805	-0.707843665045759	26	1	0.004739336492891	211	8202	1462	VCAN
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.492705490869805	-0.707843665045759	26	1	0.004739336492891	211	8202	1462	VCAN
R-HSA-2029485	Role of phospholipids in phagocytosis	0.492705490869805	-0.707843665045759	26	1	0.004739336492891	211	8202	5290	PIK3CA
R-HSA-77387	Insulin receptor recycling	0.492705490869805	-0.707843665045759	26	1	0.004739336492891	211	8202	523	ATP6V1A
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.492705490869805	-0.707843665045759	26	1	0.004739336492891	211	8202	8737	RIPK1
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.493390862704488	-0.706453594100745	64	2	0.00947867298578199	211	8202	51434,5720	ANAPC7,PSME1
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.493390862704488	-0.706453594100745	64	2	0.00947867298578199	211	8202	1308,1291	COL17A1,COL6A1
R-HSA-69202	Cyclin E associated events during G1/S transition	0.501627963047131	-0.689896543515654	65	2	0.00947867298578199	211	8202	5720,1026	PSME1,CDKN1A
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.504473714932279	-0.684239541770213	143	4	0.018957345971564	211	8202	516,4719,9123,7385	ATP5G1,NDUFS1,SLC16A3,UQCRC2
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.505797362372212	-0.681619159524179	27	1	0.004739336492891	211	8202	9564	BCAR1
R-HSA-180024	DARPP-32 events	0.505797362372212	-0.681619159524179	27	1	0.004739336492891	211	8202	5142	PDE4B
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalig pathway	0.505797362372212	-0.681619159524179	27	1	0.004739336492891	211	8202	8737	RIPK1
R-HSA-114508	Effects of PIP2 hydrolysis	0.505797362372212	-0.681619159524179	27	1	0.004739336492891	211	8202	5588	PRKCQ
R-HSA-400685	Sema4D in semaphorin signaling	0.505797362372212	-0.681619159524179	27	1	0.004739336492891	211	8202	9475	ROCK2
R-HSA-437239	Recycling pathway of L1	0.505797362372212	-0.681619159524179	27	1	0.004739336492891	211	8202	160	AP2A1
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.505797362372212	-0.681619159524179	27	1	0.004739336492891	211	8202	3635	INPP5D
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.509778891188636	-0.673778193961254	66	2	0.00947867298578199	211	8202	10484,7039	SEC23A,TGFA
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.509778891188636	-0.673778193961254	66	2	0.00947867298578199	211	8202	5720,1026	PSME1,CDKN1A
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.509980990196813	-0.673381828082359	105	3	0.014218009478673	211	8202	3725,51434,1026	JUN,ANAPC7,CDKN1A
R-HSA-69306	DNA Replication	0.516370699449538	-0.660930361647432	106	3	0.014218009478673	211	8202	6118,5720,1026	RPA2,PSME1,CDKN1A
R-HSA-373755	Semaphorin interactions	0.517842613469544	-0.658083917890741	67	2	0.00947867298578199	211	8202	10371,9475	SEMA3A,ROCK2
R-HSA-2022854	Keratan sulfate biosynthesis	0.518552928927068	-0.656713175660218	28	1	0.004739336492891	211	8202	10678	B3GNT2
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.518552928927068	-0.656713175660218	28	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.518552928927068	-0.656713175660218	28	1	0.004739336492891	211	8202	160	AP2A1
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.518552928927068	-0.656713175660218	28	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.518552928927068	-0.656713175660218	28	1	0.004739336492891	211	8202	51719	CAB39
R-HSA-202040	G-protein activation	0.518552928927068	-0.656713175660218	28	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-1483166	Synthesis of PA	0.518552928927068	-0.656713175660218	28	1	0.004739336492891	211	8202	84803	GPAT3
R-HSA-72766	Translation	0.520861835016621	-0.65227046430504	146	4	0.018957345971564	211	8202	6142,6170,6160,6235	RPL18A,RPL39,RPL31,RPS29
R-HSA-388841	Costimulation by the CD28 family	0.525818205659871	-0.64279974259983	68	2	0.00947867298578199	211	8202	1326,5290	MAP3K8,PIK3CA
R-HSA-199977	ER to Golgi Anterograde Transport	0.525818205659871	-0.64279974259983	68	2	0.00947867298578199	211	8202	10484,7039	SEC23A,TGFA
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.53098078946273	-0.633029436430929	29	1	0.004739336492891	211	8202	3725	JUN
R-HSA-445355	Smooth Muscle Contraction	0.53098078946273	-0.633029436430929	29	1	0.004739336492891	211	8202	7414	VCL
R-HSA-917977	Transferrin endocytosis and recycling	0.53098078946273	-0.633029436430929	29	1	0.004739336492891	211	8202	523	ATP6V1A
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.53098078946273	-0.633029436430929	29	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-180786	Extension of Telomeres	0.53098078946273	-0.633029436430929	29	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.53370484811762	-0.627912311708193	69	2	0.00947867298578199	211	8202	51434,5720	ANAPC7,PSME1
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.53370484811762	-0.627912311708193	69	2	0.00947867298578199	211	8202	51434,5720	ANAPC7,PSME1
R-HSA-5663205	Infectious disease	0.538887797353471	-0.618247897918521	347	9	0.042654028436019	211	8202	6170,6160,160,6235,5720,6142,60489,9636,3304	RPL39,RPL31,AP2A1,RPS29,PSME1,RPL18A,APOBEC3G,ISG15,HSPA1B
R-HSA-68949	Orc1 removal from chromatin	0.541501821026341	-0.613408849617215	70	2	0.00947867298578199	211	8202	5720,1026	PSME1,CDKN1A
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.541501821026341	-0.613408849617215	70	2	0.00947867298578199	211	8202	9636,6772	ISG15,STAT1
R-HSA-69052	Switching of origins to a post-replicative state	0.541501821026341	-0.613408849617215	70	2	0.00947867298578199	211	8202	5720,1026	PSME1,CDKN1A
R-HSA-1169408	ISG15 antiviral mechanism	0.541501821026341	-0.613408849617215	70	2	0.00947867298578199	211	8202	9636,6772	ISG15,STAT1
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.541501821026341	-0.613408849617215	70	2	0.00947867298578199	211	8202	51434,5720	ANAPC7,PSME1
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.543089324074684	-0.610481471518667	30	1	0.004739336492891	211	8202	3725	JUN
R-HSA-420092	Glucagon-type ligand receptors	0.543089324074684	-0.610481471518667	30	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-68962	Activation of the pre-replicative complex	0.543089324074684	-0.610481471518667	30	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-5683826	Surfactant metabolism	0.543089324074684	-0.610481471518667	30	1	0.004739336492891	211	8202	136	ADORA2B
R-HSA-416476	G alpha (q) signalling events	0.543522796205675	-0.609683629959763	190	5	0.023696682464455	211	8202	54331,5588,5997,5290,301	GNG2,PRKCQ,RGS2,PIK3CA,ANXA1
R-HSA-76002	Platelet activation, signaling and aggregation	0.544914523144004	-0.607126334887183	230	6	0.028436018957346	211	8202	3920,54331,5588,9564,7414,5290	LAMP2,GNG2,PRKCQ,BCAR1,VCL,PIK3CA
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.554886699574106	-0.588991330987632	31	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-1296065	Inwardly rectifying K+ channels	0.554886699574106	-0.588991330987632	31	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.554886699574106	-0.588991330987632	31	1	0.004739336492891	211	8202	7050	TGIF1
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.554886699574106	-0.588991330987632	31	1	0.004739336492891	211	8202	3304	HSPA1B
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.554886699574106	-0.588991330987632	31	1	0.004739336492891	211	8202	4325	MMP16
R-HSA-5357905	Regulation of TNFR1 signaling	0.554886699574106	-0.588991330987632	31	1	0.004739336492891	211	8202	8737	RIPK1
R-HSA-392499	Metabolism of proteins	0.555572272586235	-0.587756574699611	943	24	0.113744075829384	211	8202	516,10484,10678,7941,3489,6160,7039,6235,6142,26503,136,672,79642,29926,4189,4000,4121,2517,1912,2934,6170,1471,85365,37	ATP5G1,SEC23A,B3GNT2,PLA2G7,IGFBP6,RPL31,TGFA,RPS29,RPL18A,SLC17A5,ADORA2B,BRCA1,ARSJ,GMPPA,DNAJB9,LMNA,MAN1A1,FUCA1,PHC2,GSN,RPL39,CST3,ALG2,ACADVL
R-HSA-69300	Removal of licensing factors from origins	0.556824350972856	-0.585505437130764	72	2	0.00947867298578199	211	8202	5720,1026	PSME1,CDKN1A
R-HSA-162582	Signal Transduction	0.565429158744331	-0.570170263166455	2357	60	0.28436018957346	211	8202	7433,523,6662,5142,8737,54894,5720,3337,1026,136,54509,5997,92737,9249,5139,57534,10788,3725,650,4193,182,2905,10846,220,1291,5290,8313,79659,51384,7414,7074,154796,9475,7050,2254,79971,23526,157506,5734,5588,54492,26999,9564,133,1956,301,54331,3667,58480,817,1535,2263,160,6772,23220,51719,7088,26020,3685,2810	VIPR1,ATP6V1A,SOX9,PDE4B,RIPK1,RNF43,PSME1,DNAJB1,CDKN1A,ADORA2B,RHOF,RGS2,DNER,DHRS3,PDE3A,MIB1,IQGAP2,JUN,BMP2,MDM2,JAG1,GRIN2C,PDE10A,ALDH1A3,COL6A1,PIK3CA,AXIN2,DYNC2H1,WNT16,VCL,TIAM1,AMOT,ROCK2,TGIF1,FGF9,WLS,HMHA1,RDH10,PTGER4,PRKCQ,NEURL1B,CYFIP2,BCAR1,ADM,EGFR,ANXA1,GNG2,IRS1,RHOU,CAMK2D,CYBA,FGFR2,AP2A1,STAT1,DTX4,CAB39,TLE1,LRP10,ITGAV,SFN
R-HSA-392518	Signal amplification	0.566380874873765	-0.568488503285419	32	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.566380874873765	-0.568488503285419	32	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.566380874873765	-0.568488503285419	32	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.566380874873765	-0.568488503285419	32	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.571781865003222	-0.558997715226079	74	2	0.00947867298578199	211	8202	1912,672	PHC2,BRCA1
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.571781865003222	-0.558997715226079	74	2	0.00947867298578199	211	8202	1912,672	PHC2,BRCA1
R-HSA-113510	E2F mediated regulation of DNA replication	0.577579606260096	-0.548908999748293	33	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.577579606260096	-0.548908999748293	33	1	0.004739336492891	211	8202	5087	PBX1
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.577579606260096	-0.548908999748293	33	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-69190	DNA strand elongation	0.577579606260096	-0.548908999748293	33	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.577579606260096	-0.548908999748293	33	1	0.004739336492891	211	8202	10678	B3GNT2
R-HSA-4085001	Sialic acid metabolism	0.577579606260096	-0.548908999748293	33	1	0.004739336492891	211	8202	26503	SLC17A5
R-HSA-163359	Glucagon signaling in metabolic regulation	0.577579606260096	-0.548908999748293	33	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-69304	Regulation of DNA replication	0.579122877971281	-0.546240599450127	75	2	0.00947867298578199	211	8202	5720,1026	PSME1,CDKN1A
R-HSA-428157	Sphingolipid metabolism	0.586371755665077	-0.533801295215883	76	2	0.00947867298578199	211	8202	79642,9517	ARSJ,SPTLC2
R-HSA-390522	Striated Muscle Contraction	0.588490452525262	-0.530194575819928	34	1	0.004739336492891	211	8202	7431	VIM
R-HSA-4791275	Signaling by WNT in cancer	0.588490452525262	-0.530194575819928	34	1	0.004739336492891	211	8202	54894	RNF43
R-HSA-3928663	EPHA-mediated growth cone collapse	0.588490452525262	-0.530194575819928	34	1	0.004739336492891	211	8202	9475	ROCK2
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.588490452525262	-0.530194575819928	34	1	0.004739336492891	211	8202	5588	PRKCQ
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.588490452525262	-0.530194575819928	34	1	0.004739336492891	211	8202	9636	ISG15
R-HSA-2871837	FCERI mediated NF-kB activation	0.593528358682795	-0.521670283963084	77	2	0.00947867298578199	211	8202	5588,5720	PRKCQ,PSME1
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.599120779959315	-0.512292065200313	35	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-2514856	The phototransduction cascade	0.599120779959315	-0.512292065200313	35	1	0.004739336492891	211	8202	5588	PRKCQ
R-HSA-73884	Base Excision Repair	0.599120779959315	-0.512292065200313	35	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-194068	Bile acid and bile salt metabolism	0.599120779959315	-0.512292065200313	35	1	0.004739336492891	211	8202	8714	ABCC3
R-HSA-5693532	DNA Double-Strand Break Repair	0.603557717453031	-0.504913605150069	162	4	0.018957345971564	211	8202	6118,672,5429,197342	RPA2,BRCA1,POLH,EME2
R-HSA-2990846	SUMOylation	0.607564518825242	-0.498296905579102	79	2	0.00947867298578199	211	8202	1912,672	PHC2,BRCA1
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.609477767264501	-0.495152807732674	36	1	0.004739336492891	211	8202	79642	ARSJ
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.609477767264501	-0.495152807732674	36	1	0.004739336492891	211	8202	26999	CYFIP2
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.609477767264501	-0.495152807732674	36	1	0.004739336492891	211	8202	9517	SPTLC2
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.609477767264501	-0.495152807732674	36	1	0.004739336492891	211	8202	1956	EGFR
R-HSA-422356	Regulation of insulin secretion	0.61444412280891	-0.487037285259583	80	2	0.00947867298578199	211	8202	54331,6513	GNG2,SLC2A1
R-HSA-112316	Neuronal System	0.618997523090802	-0.479654007774364	289	7	0.033175355450237	211	8202	54331,817,4193,2905,10550,160,6505	GNG2,CAMK2D,MDM2,GRIN2C,ARL6IP5,AP2A1,SLC1A1
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.619568410320483	-0.478732155728042	37	1	0.004739336492891	211	8202	9564	BCAR1
R-HSA-156590	Glutathione conjugation	0.619568410320483	-0.478732155728042	37	1	0.004739336492891	211	8202	2941	GSTA4
R-HSA-419037	NCAM1 interactions	0.619568410320483	-0.478732155728042	37	1	0.004739336492891	211	8202	1291	COL6A1
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.619568410320483	-0.478732155728042	37	1	0.004739336492891	211	8202	1956	EGFR
R-HSA-176187	Activation of ATR in response to replication stress	0.619568410320483	-0.478732155728042	37	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-611105	Respiratory electron transport	0.621231539579988	-0.476051416974587	81	2	0.00947867298578199	211	8202	4719,7385	NDUFS1,UQCRC2
R-HSA-114608	Platelet degranulation	0.621231539579988	-0.476051416974587	81	2	0.00947867298578199	211	8202	3920,7414	LAMP2,VCL
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.621231539579988	-0.476051416974587	81	2	0.00947867298578199	211	8202	7088,5720	TLE1,PSME1
R-HSA-68874	M/G1 Transition	0.627926936319934	-0.465331462721956	82	2	0.00947867298578199	211	8202	6118,5720	RPA2,PSME1
R-HSA-69002	DNA Replication Pre-Initiation	0.627926936319934	-0.465331462721956	82	2	0.00947867298578199	211	8202	6118,5720	RPA2,PSME1
R-HSA-69242	S Phase	0.628566337914273	-0.464313706936641	125	3	0.014218009478673	211	8202	6118,5720,1026	RPA2,PSME1,CDKN1A
R-HSA-5674135	MAP2K and MAPK activation	0.629399526725535	-0.462989046297562	38	1	0.004739336492891	211	8202	7414	VCL
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.629399526725535	-0.462989046297562	38	1	0.004739336492891	211	8202	1643	DDB2
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.629399526725535	-0.462989046297562	38	1	0.004739336492891	211	8202	28232	SLCO3A1
R-HSA-69236	G1 Phase	0.629399526725535	-0.462989046297562	38	1	0.004739336492891	211	8202	1026	CDKN1A
R-HSA-1442490	Collagen degradation	0.629399526725535	-0.462989046297562	38	1	0.004739336492891	211	8202	1308	COL17A1
R-HSA-69231	Cyclin D associated events in G1	0.629399526725535	-0.462989046297562	38	1	0.004739336492891	211	8202	1026	CDKN1A
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.629399526725535	-0.462989046297562	38	1	0.004739336492891	211	8202	9636	ISG15
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.634530532452807	-0.45486987249245	83	2	0.00947867298578199	211	8202	6118,1643	RPA2,DDB2
R-HSA-977444	GABA B receptor activation	0.638977760422957	-0.447885628930208	39	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.638977760422957	-0.447885628930208	39	1	0.004739336492891	211	8202	2152	F3
R-HSA-991365	Activation of GABAB receptors	0.638977760422957	-0.447885628930208	39	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-165159	mTOR signalling	0.638977760422957	-0.447885628930208	39	1	0.004739336492891	211	8202	51719	CAB39
R-HSA-162909	Host Interactions of HIV factors	0.639283825377846	-0.447406752049078	127	3	0.014218009478673	211	8202	5720,160,60489	PSME1,AP2A1,APOBEC3G
R-HSA-912446	Meiotic recombination	0.641042596859502	-0.444659370510447	84	2	0.00947867298578199	211	8202	6118,672	RPA2,BRCA1
R-HSA-351202	Metabolism of polyamines	0.641042596859502	-0.444659370510447	84	2	0.00947867298578199	211	8202	5720,6303	PSME1,SAT1
R-HSA-111885	Opioid Signalling	0.641042596859502	-0.444659370510447	84	2	0.00947867298578199	211	8202	54331,5142	GNG2,PDE4B
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.648309586038092	-0.433386940487411	40	1	0.004739336492891	211	8202	4781	NFIB
R-HSA-1660662	Glycosphingolipid metabolism	0.648309586038092	-0.433386940487411	40	1	0.004739336492891	211	8202	79642	ARSJ
R-HSA-168253	Host Interactions with Influenza Factors	0.648309586038092	-0.433386940487411	40	1	0.004739336492891	211	8202	9636	ISG15
R-HSA-74158	RNA Polymerase III Transcription	0.648309586038092	-0.433386940487411	40	1	0.004739336492891	211	8202	4781	NFIB
R-HSA-109703	PKB-mediated events	0.648309586038092	-0.433386940487411	40	1	0.004739336492891	211	8202	51719	CAB39
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.653793437199003	-0.424963822676022	86	2	0.00947867298578199	211	8202	26999,5290	CYFIP2,PIK3CA
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.653793437199003	-0.424963822676022	86	2	0.00947867298578199	211	8202	3920,7414	LAMP2,VCL
R-HSA-75893	TNF signaling	0.657401313224984	-0.419460620149839	41	1	0.004739336492891	211	8202	8737	RIPK1
R-HSA-70153	Glucose transport	0.657401313224984	-0.419460620149839	41	1	0.004739336492891	211	8202	6513	SLC2A1
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.660032974564823	-0.415465483747845	87	2	0.00947867298578199	211	8202	7088,8313	TLE1,AXIN2
R-HSA-977225	Amyloid formation	0.666182498224301	-0.406191624620934	88	2	0.00947867298578199	211	8202	2934,1471	GSN,CST3
R-HSA-373752	Netrin-1 signaling	0.666259090814332	-0.406076658845705	42	1	0.004739336492891	211	8202	5588	PRKCQ
R-HSA-73856	RNA Polymerase II Transcription Termination	0.666259090814332	-0.406076658845705	42	1	0.004739336492891	211	8202	6628	SNRPB
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.666259090814332	-0.406076658845705	42	1	0.004739336492891	211	8202	85441	HELZ2
R-HSA-975634	Retinoid metabolism and transport	0.666259090814332	-0.406076658845705	42	1	0.004739336492891	211	8202	26020	LRP10
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.666259090814332	-0.406076658845705	42	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	0.666259090814332	-0.406076658845705	42	1	0.004739336492891	211	8202	6628	SNRPB
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.674888910900754	-0.393207178097124	43	1	0.004739336492891	211	8202	7050	TGIF1
R-HSA-73894	DNA Repair	0.678296759154092	-0.388170388936119	306	7	0.033175355450237	211	8202	6118,1643,672,2189,5429,197342,9636	RPA2,DDB2,BRCA1,FANCG,POLH,EME2,ISG15
R-HSA-4086400	PCP/CE pathway	0.684095940383561	-0.379657107476966	91	2	0.00947867298578199	211	8202	5720,160	PSME1,AP2A1
R-HSA-5668914	Diseases of metabolism	0.691487886969916	-0.368909645066301	45	1	0.004739336492891	211	8202	2232	FDXR
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.691487886969916	-0.368909645066301	45	1	0.004739336492891	211	8202	3725	JUN
R-HSA-193648	NRAGE signals death through JNK	0.691487886969916	-0.368909645066301	45	1	0.004739336492891	211	8202	7074	TIAM1
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	0.691487886969916	-0.368909645066301	45	1	0.004739336492891	211	8202	9123	SLC16A3
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.699468278765473	-0.357434834345941	46	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-194315	Signaling by Rho GTPases	0.70531977023836	-0.349104004197642	399	9	0.042654028436019	211	8202	58480,1535,23526,26999,54509,7074,9475,2810,10788	RHOU,CYBA,HMHA1,CYFIP2,RHOF,TIAM1,ROCK2,SFN,IQGAP2
R-HSA-201681	TCF dependent signaling in response to WNT	0.707223850794428	-0.346408042556547	229	5	0.023696682464455	211	8202	7088,54894,5720,6662,8313	TLE1,RNF43,PSME1,SOX9,AXIN2
R-HSA-189200	Hexose transport	0.707243192102375	-0.346380694718298	47	1	0.004739336492891	211	8202	6513	SLC2A1
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.707243192102375	-0.346380694718298	47	1	0.004739336492891	211	8202	7088	TLE1
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	0.714817893074074	-0.335727463729705	48	1	0.004739336492891	211	8202	6235	RPS29
R-HSA-73887	Death Receptor Signalling	0.714817893074074	-0.335727463729705	48	1	0.004739336492891	211	8202	8737	RIPK1
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.714817893074074	-0.335727463729705	48	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-5693607	Processing of DNA double-strand break ends	0.717567074726473	-0.331888851778376	97	2	0.00947867298578199	211	8202	6118,672	RPA2,BRCA1
R-HSA-3858494	Beta-catenin independent WNT signaling	0.721600016025618	-0.326284288025273	144	3	0.014218009478673	211	8202	54331,5720,160	GNG2,PSME1,AP2A1
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.722197513451686	-0.325456613163696	49	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.722197513451686	-0.325456613163696	49	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.722197513451686	-0.325456613163696	49	1	0.004739336492891	211	8202	2254	FGF9
R-HSA-156580	Phase II conjugation	0.722847865207781	-0.324556500531097	98	2	0.00947867298578199	211	8202	2941,6819	GSTA4,SULT1C2
R-HSA-5610787	Hedgehog 'off' state	0.728045502613653	-0.317391729148537	99	2	0.00947867298578199	211	8202	5720,79659	PSME1,DYNC2H1
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.729387054084798	-0.315550749483469	50	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.729387054084798	-0.315550749483469	50	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-169911	Regulation of Apoptosis	0.729387054084798	-0.315550749483469	50	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-191859	snRNP Assembly	0.729387054084798	-0.315550749483469	50	1	0.004739336492891	211	8202	6628	SNRPB
R-HSA-194441	Metabolism of non-coding RNA	0.729387054084798	-0.315550749483469	50	1	0.004739336492891	211	8202	6628	SNRPB
R-HSA-72165	mRNA Splicing - Minor Pathway	0.729387054084798	-0.315550749483469	50	1	0.004739336492891	211	8202	6628	SNRPB
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.729387054084798	-0.315550749483469	50	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.729387054084798	-0.315550749483469	50	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-180534	Vpu mediated degradation of CD4	0.736391388175182	-0.30599352418483	51	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-1592230	Mitochondrial biogenesis	0.736391388175182	-0.30599352418483	51	1	0.004739336492891	211	8202	85441	HELZ2
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.736391388175182	-0.30599352418483	51	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-1268020	Mitochondrial protein import	0.743215264636316	-0.296769552624116	52	1	0.004739336492891	211	8202	516	ATP5G1
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.743215264636316	-0.296769552624116	52	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.743215264636316	-0.296769552624116	52	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-69610	p53-Independent DNA Damage Response	0.743215264636316	-0.296769552624116	52	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-114604	GPVI-mediated activation cascade	0.756340037310846	-0.279264219122761	54	1	0.004739336492891	211	8202	5290	PIK3CA
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.756340037310846	-0.279264219122761	54	1	0.004739336492891	211	8202	1462	VCAN
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.756340037310846	-0.279264219122761	54	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.756340037310846	-0.279264219122761	54	1	0.004739336492891	211	8202	2495	FTH1
R-HSA-72702	Ribosomal scanning and start codon recognition	0.762649837526877	-0.270956281573814	55	1	0.004739336492891	211	8202	6235	RPS29
R-HSA-72649	Translation initiation complex formation	0.762649837526877	-0.270956281573814	55	1	0.004739336492891	211	8202	6235	RPS29
R-HSA-2142753	Arachidonic acid metabolism	0.762649837526877	-0.270956281573814	55	1	0.004739336492891	211	8202	4048	LTA4H
R-HSA-977443	GABA receptor activation	0.762649837526877	-0.270956281573814	55	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-6784531	tRNA processing in the nucleus	0.762649837526877	-0.270956281573814	55	1	0.004739336492891	211	8202	10940	POP1
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.762649837526877	-0.270956281573814	55	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.762649837526877	-0.270956281573814	55	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-163685	Integration of energy metabolism	0.766727336177932	-0.265624034718818	107	2	0.00947867298578199	211	8202	54331,6513	GNG2,SLC2A1
R-HSA-4641258	Degradation of DVL	0.768796994061373	-0.262928331243463	56	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	0.768796994061373	-0.262928331243463	56	1	0.004739336492891	211	8202	6235	RPS29
R-HSA-5696398	Nucleotide Excision Repair	0.775622598730125	-0.254089218944093	109	2	0.00947867298578199	211	8202	6118,1643	RPA2,DDB2
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.780619961178602	-0.247666852978401	58	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.780619961178602	-0.247666852978401	58	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.786303800572791	-0.240412046506852	59	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.786303800572791	-0.240412046506852	59	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.786303800572791	-0.240412046506852	59	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.786303800572791	-0.240412046506852	59	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-72163	mRNA Splicing - Major Pathway	0.79253080554743	-0.232523902632949	113	2	0.00947867298578199	211	8202	6628,1660	SNRPB,DHX9
R-HSA-4086398	Ca2+ pathway	0.797235500083477	-0.226605160672256	61	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.797235500083477	-0.226605160672256	61	1	0.004739336492891	211	8202	26999	CYFIP2
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.797235500083477	-0.226605160672256	61	1	0.004739336492891	211	8202	7074	TIAM1
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.802490789286061	-0.220034901568992	62	1	0.004739336492891	211	8202	2810	SFN
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	0.807610499787775	-0.213675391404871	63	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-4608870	Asymmetric localization of PCP proteins	0.807610499787775	-0.213675391404871	63	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-5358346	Hedgehog ligand biogenesis	0.81259811307778	-0.207518617511222	64	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-6782135	Dual incision in TC-NER	0.81259811307778	-0.207518617511222	64	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-913709	O-linked glycosylation of mucins	0.81259811307778	-0.207518617511222	64	1	0.004739336492891	211	8202	10678	B3GNT2
R-HSA-72172	mRNA Splicing	0.819436372963719	-0.199138525101427	120	2	0.00947867298578199	211	8202	6628,1660	SNRPB,DHX9
R-HSA-1169091	Activation of NF-kappaB in B cells	0.822190531364655	-0.195783120803772	66	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-68882	Mitotic Anaphase	0.824450022466856	-0.19303875438444	172	3	0.014218009478673	211	8202	51434,5720,4000	ANAPC7,PSME1,LMNA
R-HSA-5658442	Regulation of RAS by GAPs	0.826801863467654	-0.190190197345842	67	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-68867	Assembly of the pre-replicative complex	0.826801863467654	-0.190190197345842	67	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.827437447433268	-0.189421766813814	173	3	0.014218009478673	211	8202	51434,5720,4000	ANAPC7,PSME1,LMNA
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.831294156860207	-0.18477156738811	68	1	0.004739336492891	211	8202	672	BRCA1
R-HSA-421837	Clathrin derived vesicle budding	0.839933783981466	-0.174432218845408	70	1	0.004739336492891	211	8202	2495	FTH1
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.839933783981466	-0.174432218845408	70	1	0.004739336492891	211	8202	2495	FTH1
R-HSA-2299718	Condensation of Prophase Chromosomes	0.844087002330192	-0.16949970636929	71	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-5617833	Assembly of the primary cilium	0.847159332316164	-0.165866488306769	180	3	0.014218009478673	211	8202	79659,79867,56912	DYNC2H1,TCTN2,IFT46
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.848132955151303	-0.164717868744963	72	1	0.004739336492891	211	8202	7050	TGIF1
R-HSA-212436	Generic Transcription Pathway	0.851257901757808	-0.161040139026628	553	11	0.0521327014218009	211	8202	171392,7050,85441,143686,860,5468,50484,80818,27244,2810,7025	ZNF675,TGIF1,HELZ2,SESN3,RUNX2,PPARG,RRM2B,ZNF436,SESN1,SFN,NR2F1
R-HSA-380287	Centrosome maturation	0.85207439998916	-0.160081432034394	73	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.85207439998916	-0.160081432034394	73	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	0.855914023754183	-0.15558534742429	74	1	0.004739336492891	211	8202	672	BRCA1
R-HSA-5693606	DNA Double Strand Break Response	0.859654444650115	-0.151224779027646	75	1	0.004739336492891	211	8202	672	BRCA1
R-HSA-195258	RHO GTPase Effectors	0.863152770846246	-0.147163580568623	285	5	0.023696682464455	211	8202	26999,1535,9475,2810,10788	CYFIP2,CYBA,ROCK2,SFN,IQGAP2
R-HSA-5358351	Signaling by Hedgehog	0.866847734192036	-0.142891941394534	135	2	0.00947867298578199	211	8202	5720,79659	PSME1,DYNC2H1
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	0.866847817183999	-0.142891845654583	77	1	0.004739336492891	211	8202	1026	CDKN1A
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	0.866847817183999	-0.142891845654583	77	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-68875	Mitotic Prophase	0.869564568792537	-0.13976268826402	136	2	0.00947867298578199	211	8202	891,4000	CCNB1,LMNA
R-HSA-157579	Telomere Maintenance	0.87030567695267	-0.138910776224294	78	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.872230610105279	-0.136701428906931	137	2	0.00947867298578199	211	8202	50808,3659	AK3,IRF1
R-HSA-1640170	Cell Cycle	0.879168411118515	-0.12877880565726	572	11	0.0521327014218009	211	8202	7153,6118,4193,23224,5720,51434,672,1026,891,2810,4000	TOP2A,RPA2,MDM2,SYNE2,PSME1,ANAPC7,BRCA1,CDKN1A,CCNB1,SFN,LMNA
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.880152096219173	-0.127660549831715	81	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-5653656	Vesicle-mediated transport	0.880268369794086	-0.127528452327366	294	5	0.023696682464455	211	8202	10484,2495,10808,7039,2810	SEC23A,FTH1,HSPH1,TGFA,SFN
R-HSA-193704	p75 NTR receptor-mediated signalling	0.883265987088344	-0.124128892608538	82	1	0.004739336492891	211	8202	7074	TIAM1
R-HSA-5419276	Mitochondrial translation termination	0.889254246880122	-0.117372092365008	84	1	0.004739336492891	211	8202	55173	MRPS10
R-HSA-5632684	Hedgehog 'on' state	0.889254246880122	-0.117372092365008	84	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-5389840	Mitochondrial translation elongation	0.889254246880122	-0.117372092365008	84	1	0.004739336492891	211	8202	55173	MRPS10
R-HSA-5368286	Mitochondrial translation initiation	0.889254246880122	-0.117372092365008	84	1	0.004739336492891	211	8202	55173	MRPS10
R-HSA-2980736	Peptide hormone metabolism	0.894936700233509	-0.111002289204562	86	1	0.004739336492891	211	8202	7941	PLA2G7
R-HSA-199991	Membrane Trafficking	0.900610254034335	-0.104682685398521	256	4	0.018957345971564	211	8202	10484,2495,7039,2810	SEC23A,FTH1,TGFA,SFN
R-HSA-196854	Metabolism of vitamins and cofactors	0.905445585866959	-0.0993280963776732	90	1	0.004739336492891	211	8202	6513	SLC2A1
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.905445585866959	-0.0993280963776732	90	1	0.004739336492891	211	8202	79867	TCTN2
R-HSA-5368287	Mitochondrial translation	0.905445585866959	-0.0993280963776732	90	1	0.004739336492891	211	8202	55173	MRPS10
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.905445585866959	-0.0993280963776732	90	1	0.004739336492891	211	8202	6513	SLC2A1
R-HSA-5625740	RHO GTPases activate PKNs	0.905445585866959	-0.0993280963776732	90	1	0.004739336492891	211	8202	2810	SFN
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.908608382190021	-0.0958411003086541	153	2	0.00947867298578199	211	8202	6628,1660	SNRPB,DHX9
R-HSA-72306	tRNA processing	0.914907808985149	-0.0889319739902505	94	1	0.004739336492891	211	8202	10940	POP1
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.919279271839989	-0.0841653161312484	96	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-1852241	Organelle biogenesis and maintenance	0.921112830204152	-0.0821727418653814	321	5	0.023696682464455	211	8202	55173,85441,79659,79867,56912	MRPS10,HELZ2,DYNC2H1,TCTN2,IFT46
R-HSA-2467813	Separation of Sister Chromatids	0.922939778835968	-0.080191291639289	161	2	0.00947867298578199	211	8202	51434,5720	ANAPC7,PSME1
R-HSA-2672351	Stimuli-sensing channels	0.925420858590515	-0.0775066626827395	99	1	0.004739336492891	211	8202	6446	SGK1
R-HSA-1296071	Potassium Channels	0.925420858590515	-0.0775066626827395	99	1	0.004739336492891	211	8202	54331	GNG2
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.925420858590515	-0.0775066626827395	99	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.927362879927838	-0.0754103337824487	100	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-162906	HIV Infection	0.927716106379596	-0.0750295128485329	221	3	0.014218009478673	211	8202	5720,160,60489	PSME1,AP2A1,APOBEC3G
R-HSA-5173105	O-linked glycosylation	0.932892087489961	-0.0694657466784168	103	1	0.004739336492891	211	8202	10678	B3GNT2
R-HSA-73886	Chromosome Maintenance	0.936343420174902	-0.0657729679003242	105	1	0.004739336492891	211	8202	6118	RPA2
R-HSA-73857	RNA Polymerase II Transcription	0.93961805021664	-0.0622818158490771	107	1	0.004739336492891	211	8202	6628	SNRPB
R-HSA-68877	Mitotic Prometaphase	0.941191934256735	-0.0606081918036279	108	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-68886	M Phase	0.950273485878021	-0.0510054559454086	296	4	0.018957345971564	211	8202	51434,5720,891,4000	ANAPC7,PSME1,CCNB1,LMNA
R-HSA-69275	G2/M Transition	0.951122947924228	-0.0501119420125738	115	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.951122947924228	-0.0501119420125738	115	1	0.004739336492891	211	8202	3107	HLA-C
R-HSA-453274	Mitotic G2-G2/M phases	0.95364035580505	-0.0474686641400568	117	1	0.004739336492891	211	8202	891	CCNB1
R-HSA-5621481	C-type lectin receptors (CLRs)	0.960444141920812	-0.0403594536745879	123	1	0.004739336492891	211	8202	5720	PSME1
R-HSA-983712	Ion channel transport	0.96574948988529	-0.0348508056416428	198	2	0.00947867298578199	211	8202	6446,523	SGK1,ATP6V1A
R-HSA-69278	Cell Cycle, Mitotic	0.96633528996279	-0.034244413932997	477	7	0.033175355450237	211	8202	7153,6118,51434,5720,1026,891,4000	TOP2A,RPA2,ANAPC7,PSME1,CDKN1A,CCNB1,LMNA
R-HSA-372790	Signaling by GPCR	0.967269264673866	-0.033278368645741	1230	23	0.109004739336493	211	8202	7433,2254,5142,5734,5588,5720,136,5997,133,5139,1956,301,54331,3667,817,2905,2263,10846,5290,51384,7414,7074,9475	VIPR1,FGF9,PDE4B,PTGER4,PRKCQ,PSME1,ADORA2B,RGS2,ADM,PDE3A,EGFR,ANXA1,GNG2,IRS1,CAMK2D,GRIN2C,FGFR2,PDE10A,PIK3CA,WNT16,VCL,TIAM1,ROCK2
R-HSA-71291	Metabolism of amino acids and derivatives	0.975002160644134	-0.0253155919414794	212	2	0.00947867298578199	211	8202	5720,6303	PSME1,SAT1
R-HSA-500792	GPCR ligand binding	0.975329946982605	-0.0249794580694327	444	6	0.028436018957346	211	8202	54331,51384,136,133,5734,301	GNG2,WNT16,ADORA2B,ADM,PTGER4,ANXA1
R-HSA-3214847	HATs acetylate histones	0.976715263870376	-0.023560108647979	143	1	0.004739336492891	211	8202	54556	ING3
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.977918653699692	-0.0223287885828334	145	1	0.004739336492891	211	8202	4781	NFIB
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.980533896976405	-0.0196580628301928	223	2	0.00947867298578199	211	8202	51434,5720	ANAPC7,PSME1
R-HSA-74160	Gene Expression	0.982258515149469	-0.0179007515564871	1330	24	0.113744075829384	211	8202	171392,7050,860,5468,6160,6628,196513,6235,1660,677,6142,5720,85456,27244,4781,7025,3304,10940,85441,143686,50484,6170,80818,2810	ZNF675,TGIF1,RUNX2,PPARG,RPL31,SNRPB,DCP1B,RPS29,DHX9,ZFP36L1,RPL18A,PSME1,TNKS1BP1,SESN1,NFIB,NR2F1,HSPA1B,POP1,HELZ2,SESN3,RRM2B,RPL39,ZNF436,SFN
R-HSA-418594	G alpha (i) signalling events	0.985556042055646	-0.0145492873845475	236	2	0.00947867298578199	211	8202	54331,301	GNG2,ANXA1
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.989849575831808	-0.0102022910023351	318	3	0.014218009478673	211	8202	136,5734,301	ADORA2B,PTGER4,ANXA1
R-HSA-388396	GPCR downstream signaling	0.992445441473201	-0.00758323873959933	928	14	0.0663507109004739	211	8202	54331,7433,10846,5142,5290,5734,5588,136,5997,7074,9475,133,5139,301	GNG2,VIPR1,PDE10A,PDE4B,PIK3CA,PTGER4,PRKCQ,ADORA2B,RGS2,TIAM1,ROCK2,ADM,PDE3A,ANXA1
R-HSA-375276	Peptide ligand-binding receptors	0.993845666935579	-0.00617334903270242	193	1	0.004739336492891	211	8202	301	ANXA1
R-HSA-4839726	Chromatin organization	0.999006071461656	-0.000994422812856951	261	1	0.004739336492891	211	8202	54556	ING3
R-HSA-3247509	Chromatin modifying enzymes	0.999006071461656	-0.000994422812856951	261	1	0.004739336492891	211	8202	54556	ING3
R-HSA-416700	Other semaphorin interactions	0.999999999966881	-3.31191550331636e-11	19	0	0	211	8202
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.999999999966881	-3.31191550331636e-11	19	0	0	211	8202
R-HSA-190861	Gap junction assembly	0.999999999966881	-3.31191550331636e-11	19	0	0	211	8202
R-HSA-1181150	Signaling by NODAL	0.999999999966881	-3.31191550331636e-11	19	0	0	211	8202
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999966881	-3.31191550331636e-11	19	0	0	211	8202
R-HSA-418360	Platelet calcium homeostasis	0.999999999966881	-3.31191550331636e-11	19	0	0	211	8202
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.999999999966881	-3.31191550331636e-11	19	0	0	211	8202
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.999999999966881	-3.31191550331636e-11	19	0	0	211	8202
R-HSA-194002	Glucocorticoid biosynthesis	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-425561	Sodium/Calcium exchangers	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-156587	Amino Acid conjugation	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-162592	Integration of provirus	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-2243919	Crosslinking of collagen fibrils	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-1300642	Sperm Motility And Taxes	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-425986	Sodium/Proton exchangers	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-425381	Bicarbonate transporters	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-428543	Inactivation of Cdc42 and Rac	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-70635	Urea cycle	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-112411	MAPK1 (ERK2) activation	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-390696	Adrenoceptors	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-419408	Lysosphingolipid and LPA receptors	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-727802	Transport of nucleotide sugars	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-193697	p75NTR regulates axonogenesis	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-159424	Conjugation of carboxylic acids	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-196025	Formation of annular gap junctions	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-447041	CHL1 interactions	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-2428933	SHC-related events triggered by IGF1R	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-1296052	Ca2+ activated K+ channels	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-201688	WNT mediated activation of DVL	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-159740	Gamma-carboxylation of protein precursors	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-3215018	Processing and activation of SUMO	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-1462054	Alpha-defensins	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-390450	Folding of actin by CCT/TriC	0.999999999971053	-2.89473483443195e-11	9	0	0	211	8202
R-HSA-167021	PLC-gamma1 signalling	0.999999999971628	-2.83719633586052e-11	36	0	0	211	8202
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.999999999971628	-2.83719633586052e-11	36	0	0	211	8202
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.999999999971628	-2.83719633586052e-11	36	0	0	211	8202
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.9999999999758	-2.4199582658896e-11	15	0	0	211	8202
R-HSA-209952	Peptide hormone biosynthesis	0.9999999999758	-2.4199582658896e-11	15	0	0	211	8202
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.9999999999758	-2.4199582658896e-11	15	0	0	211	8202
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.9999999999758	-2.4199582658896e-11	15	0	0	211	8202
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.9999999999758	-2.4199582658896e-11	15	0	0	211	8202
R-HSA-901042	Calnexin/calreticulin cycle	0.9999999999758	-2.4199582658896e-11	15	0	0	211	8202
R-HSA-549132	Organic cation/anion/zwitterion transport	0.9999999999758	-2.4199582658896e-11	15	0	0	211	8202
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.9999999999758	-2.4199582658896e-11	15	0	0	211	8202
R-HSA-194223	HDL-mediated lipid transport	0.9999999999758	-2.4199582658896e-11	15	0	0	211	8202
R-HSA-205043	NRIF signals cell death from the nucleus	0.9999999999758	-2.4199582658896e-11	15	0	0	211	8202
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.9999999999758	-2.4199582658896e-11	15	0	0	211	8202
R-HSA-975577	N-Glycan antennae elongation	0.9999999999758	-2.4199582658896e-11	15	0	0	211	8202
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.9999999999758	-2.4199582658896e-11	15	0	0	211	8202
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.9999999999758	-2.4199582658896e-11	15	0	0	211	8202
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.9999999999758	-2.4199582658896e-11	15	0	0	211	8202
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.9999999999758	-2.4199582658896e-11	15	0	0	211	8202
R-HSA-164944	Nef and signal transduction	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-1253288	Downregulation of ERBB4 signaling	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-5619115	Disorders of transmembrane transporters	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-1483115	Hydrolysis of LPC	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-400451	Free fatty acids regulate insulin secretion	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-73928	Depyrimidination	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-110329	Cleavage of the damaged pyrimidine	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-804914	Transport of fatty acids	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-196783	Coenzyme A biosynthesis	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-444821	Relaxin receptors	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-177128	Conjugation of salicylate with glycine	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-194313	VEGF ligand-receptor interactions	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-72731	Recycling of eIF2:GDP	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-5632681	Ligand-receptor interactions	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-1614558	Degradation of cysteine and homocysteine	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-2046105	Linoleic acid (LA) metabolism	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-192456	Digestion of dietary lipid	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-163765	ChREBP activates metabolic gene expression	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.999999999976502	-2.34978203185176e-11	8	0	0	211	8202
R-HSA-162594	Early Phase of HIV Life Cycle	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-428540	Activation of Rac	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-418885	DCC mediated attractive signaling	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-5682910	LGI-ADAM interactions	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-69091	Polymerase switching	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-69109	Leading Strand Synthesis	0.999999999976537	-2.34631438689222e-11	14	0	0	211	8202
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999976925	-2.30747515304021e-11	18	0	0	211	8202
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.999999999976925	-2.30747515304021e-11	18	0	0	211	8202
R-HSA-209776	Amine-derived hormones	0.999999999976925	-2.30747515304021e-11	18	0	0	211	8202
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.999999999976925	-2.30747515304021e-11	18	0	0	211	8202
R-HSA-5635838	Activation of SMO	0.999999999976925	-2.30747515304021e-11	18	0	0	211	8202
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.999999999976925	-2.30747515304021e-11	18	0	0	211	8202
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.999999999976925	-2.30747515304021e-11	18	0	0	211	8202
R-HSA-73780	RNA Polymerase III Chain Elongation	0.999999999976925	-2.30747515304021e-11	18	0	0	211	8202
R-HSA-5223345	Miscellaneous transport and binding events	0.999999999976925	-2.30747515304021e-11	18	0	0	211	8202
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.999999999976925	-2.30747515304021e-11	18	0	0	211	8202
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.999999999977988	-2.20119634570248e-11	24	0	0	211	8202
R-HSA-379716	Cytosolic tRNA aminoacylation	0.999999999977988	-2.20119634570248e-11	24	0	0	211	8202
R-HSA-1614635	Sulfur amino acid metabolism	0.999999999977988	-2.20119634570248e-11	24	0	0	211	8202
R-HSA-977606	Regulation of Complement cascade	0.999999999977988	-2.20119634570248e-11	24	0	0	211	8202
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.999999999977988	-2.20119634570248e-11	24	0	0	211	8202
R-HSA-5260271	Diseases of Immune System	0.999999999977988	-2.20119634570248e-11	24	0	0	211	8202
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.999999999977988	-2.20119634570248e-11	24	0	0	211	8202
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-265473	Trafficking of dietary sterols	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-70350	Fructose catabolism	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-1483152	Hydrolysis of LPE	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-77108	Utilization of Ketone Bodies	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-191650	Regulation of gap junction activity	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-163282	Mitochondrial transcription initiation	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-193681	Ceramide signalling	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-977347	Serine biosynthesis	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-198745	Signalling to STAT3	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-844455	The NLRP1 inflammasome	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-177539	Autointegration results in viral DNA circles	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-5357572	Lysosomal glycogen catabolism	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-190704	Oligomerization of connexins into connexons	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-110331	Cleavage of the damaged purine	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-3249367	STAT6-mediated induction of chemokines	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-1296067	Potassium transport channels	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-977442	GABA A (rho) receptor activation	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-217271	FMO oxidises nucleophiles	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-5602571	TRAF3 deficiency - HSE	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-73927	Depurination	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-190827	Transport of connexins along the secretory pathway	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-844615	The AIM2 inflammasome	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-1307965	betaKlotho-mediated ligand binding	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.999999999978255	-2.17446324990856e-11	3	0	0	211	8202
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-916853	Degradation of GABA	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-205017	NFG and proNGF binds to p75NTR	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-168277	Influenza Virus Induced Apoptosis	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-168268	Virus Assembly and Release	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-1483101	Synthesis of PS	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-192905	vRNP Assembly	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-5652227	Fructose biosynthesis	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-141334	PAOs oxidise polyamines to amines	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-75102	C6 deamination of adenosine	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-844623	The IPAF inflammasome	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-1614603	Cysteine formation from homocysteine	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-380612	Metabolism of serotonin	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-75064	mRNA Editing: A to I Conversion	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-156582	Acetylation	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-141424	Amplification of signal from the kinetochores	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-888568	GABA synthesis	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-190872	Transport of connexons to the plasma membrane	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-165160	PDE3B signalling	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-203754	NOSIP mediated eNOS trafficking	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-198765	Signalling to ERK5	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-351143	Agmatine biosynthesis	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-70688	Proline catabolism	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-187042	TRKA activation by NGF	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-75094	Formation of the Editosome	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-5602566	TICAM1 deficiency - HSE	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-5602636	IKBKB deficiency causes SCID	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-111995	phospho-PLA2 pathway	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-77042	Formation of editosomes by ADAR proteins	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-111452	Activation and oligomerization of BAK protein	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-1483226	Synthesis of PI	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-5662702	Melanin biosynthesis	0.999999999978645	-2.13554639466942e-11	2	0	0	211	8202
R-HSA-5336415	Uptake and function of diphtheria toxin	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-68952	DNA replication initiation	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-70921	Histidine catabolism	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-388479	Vasopressin-like receptors	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-500753	Pyrimidine biosynthesis	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-171052	LDL-mediated lipid transport	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-190370	FGFR1b ligand binding and activation	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-5660668	CLEC7A/inflammasome pathway	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-1482798	Acyl chain remodeling of CL	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-1237112	Methionine salvage pathway	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-1566977	Fibronectin matrix formation	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-171319	Telomere Extension By Telomerase	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-174362	Transport and synthesis of PAPS	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-193993	Mineralocorticoid biosynthesis	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-947581	Molybdenum cofactor biosynthesis	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-5626978	TNFR1-mediated ceramide production	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-77111	Synthesis of Ketone Bodies	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-173623	Classical antibody-mediated complement activation	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-205025	NADE modulates death signalling	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-111957	Cam-PDE 1 activation	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-187015	Activation of TRKA receptors	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-3065679	SUMO is proteolytically processed	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-174430	Telomere C-strand synthesis initiation	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-177135	Conjugation of benzoate with glycine	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-73942	DNA Damage Reversal	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-428808	Na+-dependent glucose transporters	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-444257	RSK activation	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-166662	Lectin pathway of complement activation	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-189483	Heme degradation	0.999999999979344	-2.0655875743449e-11	6	0	0	211	8202
R-HSA-168325	Viral Messenger RNA Synthesis	0.999999999979356	-2.06445083867595e-11	41	0	0	211	8202
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-5625970	RHO GTPases activate KTN1	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-196780	Biotin transport and metabolism	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-71288	Creatine metabolism	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-2485179	Activation of the phototransduction cascade	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-68689	CDC6 association with the ORC:origin complex	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-376172	DSCAM interactions	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-199983	Golgi to ER Retrograde Transport	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-199997	COPI Mediated Transport	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-196757	Metabolism of folate and pterines	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-71064	Lysine catabolism	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-375281	Hormone ligand-binding receptors	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-1266695	Interleukin-7 signaling	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-211999	CYP2E1 reactions	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-193048	Androgen biosynthesis	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-71240	Tryptophan catabolism	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-196807	Nicotinate metabolism	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.999999999980156	-1.98443303648357e-11	11	0	0	211	8202
R-HSA-167287	HIV elongation arrest and recovery	0.999999999980197	-1.98026466628259e-11	31	0	0	211	8202
R-HSA-352230	Amino acid transport across the plasma membrane	0.999999999980197	-1.98026466628259e-11	31	0	0	211	8202
R-HSA-167290	Pausing and recovery of HIV elongation	0.999999999980197	-1.98026466628259e-11	31	0	0	211	8202
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.999999999980197	-1.98026466628259e-11	31	0	0	211	8202
R-HSA-73772	RNA Polymerase I Promoter Escape	0.999999999980197	-1.98026466628259e-11	31	0	0	211	8202
R-HSA-70171	Glycolysis	0.999999999980197	-1.98026466628259e-11	31	0	0	211	8202
R-HSA-2022928	HS-GAG biosynthesis	0.999999999980197	-1.98026466628259e-11	31	0	0	211	8202
R-HSA-180746	Nuclear import of Rev protein	0.999999999980197	-1.98026466628259e-11	31	0	0	211	8202
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.999999999980197	-1.98026466628259e-11	31	0	0	211	8202
R-HSA-5663084	Diseases of carbohydrate metabolism	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-168799	Neurotoxicity of clostridium toxins	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-209968	Thyroxine biosynthesis	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-381183	ATF6-alpha activates chaperone genes	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-419771	Opsins	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-193692	Regulated proteolysis of p75NTR	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-3229121	Glycogen storage diseases	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-2474795	Diseases associated with visual transduction	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-937039	IRAK1 recruits IKK complex	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-2470946	Cohesin Loading onto Chromatin	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-418886	Netrin mediated repulsion signals	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-549127	Organic cation transport	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-430116	GP1b-IX-V activation signalling	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-110056	MAPK3 (ERK1) activation	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-399997	Acetylcholine regulates insulin secretion	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-2453864	Retinoid cycle disease events	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-1300644	Interaction With The Zona Pellucida	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-1433617	Regulation of signaling by NODAL	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-5621480	Dectin-2 family	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-170660	Adenylate cyclase activating pathway	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-190873	Gap junction degradation	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-418889	Ligand-independent caspase activation via DCC	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999980256	-1.97439611700345e-11	10	0	0	211	8202
R-HSA-5423646	Aflatoxin activation and detoxification	0.999999999981291	-1.87093732567782e-11	22	0	0	211	8202
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.999999999981291	-1.87093732567782e-11	22	0	0	211	8202
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.999999999981291	-1.87093732567782e-11	22	0	0	211	8202
R-HSA-203765	eNOS activation and regulation	0.999999999981291	-1.87093732567782e-11	22	0	0	211	8202
R-HSA-5205647	Mitophagy	0.999999999981291	-1.87093732567782e-11	22	0	0	211	8202
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.999999999981291	-1.87093732567782e-11	22	0	0	211	8202
R-HSA-166208	mTORC1-mediated signalling	0.999999999981291	-1.87093732567782e-11	22	0	0	211	8202
R-HSA-389513	CTLA4 inhibitory signaling	0.999999999981291	-1.87093732567782e-11	22	0	0	211	8202
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.999999999981291	-1.87093732567782e-11	22	0	0	211	8202
R-HSA-202131	Metabolism of nitric oxide	0.999999999981291	-1.87093732567782e-11	22	0	0	211	8202
R-HSA-166663	Initial triggering of complement	0.999999999982471	-1.75287341222869e-11	20	0	0	211	8202
R-HSA-210745	Regulation of gene expression in beta cells	0.999999999982471	-1.75287341222869e-11	20	0	0	211	8202
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.999999999982471	-1.75287341222869e-11	20	0	0	211	8202
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.999999999982471	-1.75287341222869e-11	20	0	0	211	8202
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-71262	Carnitine synthesis	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-193144	Estrogen biosynthesis	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-173736	Alternative complement activation	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-1296061	HCN channels	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-75072	mRNA Editing	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-1296053	Classical Kir channels	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-6783984	Glycine degradation	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-2473224	Antagonism of Activin by Follistatin	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-888593	Reuptake of GABA	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-427975	Proton/oligopeptide cotransporters	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-1855191	Synthesis of IPs in the nucleus	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-75896	Plasmalogen biosynthesis	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-3000497	Scavenging by Class H Receptors	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-399710	Activation of AMPA receptors	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-389599	Alpha-oxidation of phytanate	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-209905	Catecholamine biosynthesis	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-209563	Axonal growth stimulation	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-196819	Vitamin B1 (thiamin) metabolism	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-140179	Amine Oxidase reactions	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-428776	Class II GLUTs	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-165158	Activation of AKT2	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-173107	Binding and entry of HIV virion	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-442745	Activation of CaMK IV	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-1296025	ATP sensitive Potassium channels	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-390650	Histamine receptors	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-167060	NGF processing	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.999999999983604	-1.63955131454454e-11	4	0	0	211	8202
R-HSA-1482922	Acyl chain remodelling of PI	0.999999999984375	-1.56253697344677e-11	16	0	0	211	8202
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.999999999984375	-1.56253697344677e-11	16	0	0	211	8202
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.999999999984375	-1.56253697344677e-11	16	0	0	211	8202
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.999999999984375	-1.56253697344677e-11	16	0	0	211	8202
R-HSA-1170546	Prolactin receptor signaling	0.999999999984375	-1.56253697344677e-11	16	0	0	211	8202
R-HSA-193639	p75NTR signals via NF-kB	0.999999999984375	-1.56253697344677e-11	16	0	0	211	8202
R-HSA-1433559	Regulation of KIT signaling	0.999999999984375	-1.56253697344677e-11	16	0	0	211	8202
R-HSA-1295596	Spry regulation of FGF signaling	0.999999999984375	-1.56253697344677e-11	16	0	0	211	8202
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.999999999984375	-1.56253697344677e-11	16	0	0	211	8202
R-HSA-392517	Rap1 signalling	0.999999999984375	-1.56253697344677e-11	16	0	0	211	8202
R-HSA-163615	PKA activation	0.999999999984375	-1.56253697344677e-11	16	0	0	211	8202
R-HSA-5625900	RHO GTPases activate CIT	0.999999999984375	-1.56253697344677e-11	16	0	0	211	8202
R-HSA-446353	Cell-extracellular matrix interactions	0.999999999984375	-1.56253697344677e-11	16	0	0	211	8202
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.999999999984375	-1.56253697344677e-11	16	0	0	211	8202
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.99999999998528	-1.47197515792152e-11	27	0	0	211	8202
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.99999999998528	-1.47197515792152e-11	27	0	0	211	8202
R-HSA-192105	Synthesis of bile acids and bile salts	0.99999999998528	-1.47197515792152e-11	27	0	0	211	8202
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.999999999986057	-1.39432388331831e-11	44	0	0	211	8202
R-HSA-75955	RNA Polymerase II Transcription Elongation	0.999999999986057	-1.39432388331831e-11	44	0	0	211	8202
R-HSA-112382	Formation of RNA Pol II elongation complex	0.999999999986057	-1.39432388331831e-11	44	0	0	211	8202
R-HSA-379724	tRNA Aminoacylation	0.999999999986549	-1.34505289159662e-11	42	0	0	211	8202
R-HSA-375280	Amine ligand-binding receptors	0.999999999986549	-1.34505289159662e-11	42	0	0	211	8202
R-HSA-1461957	Beta defensins	0.999999999986549	-1.34505289159662e-11	42	0	0	211	8202
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.999999999986596	-1.34043584492564e-11	32	0	0	211	8202
R-HSA-202433	Generation of second messenger molecules	0.999999999986596	-1.34043584492564e-11	32	0	0	211	8202
R-HSA-186712	Regulation of beta-cell development	0.999999999986596	-1.34043584492564e-11	32	0	0	211	8202
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.999999999986596	-1.34043584492564e-11	32	0	0	211	8202
R-HSA-73863	RNA Polymerase I Transcription Termination	0.999999999986596	-1.34043584492564e-11	32	0	0	211	8202
R-HSA-376176	Signaling by Robo receptor	0.999999999986596	-1.34043584492564e-11	32	0	0	211	8202
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.999999999986596	-1.34043584492564e-11	32	0	0	211	8202
R-HSA-70895	Branched-chain amino acid catabolism	0.999999999986958	-1.30422472540148e-11	23	0	0	211	8202
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.999999999986958	-1.30422472540148e-11	23	0	0	211	8202
R-HSA-389948	PD-1 signaling	0.999999999986958	-1.30422472540148e-11	23	0	0	211	8202
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.999999999986958	-1.30422472540148e-11	23	0	0	211	8202
R-HSA-5627123	RHO GTPases activate PAKs	0.999999999986958	-1.30422472540148e-11	23	0	0	211	8202
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.999999999986958	-1.30422472540148e-11	23	0	0	211	8202
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.999999999986958	-1.30422472540148e-11	23	0	0	211	8202
R-HSA-112409	RAF-independent MAPK1/3 activation	0.999999999986958	-1.30422472540148e-11	23	0	0	211	8202
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.999999999986958	-1.30422472540148e-11	23	0	0	211	8202
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.999999999986958	-1.30422472540148e-11	23	0	0	211	8202
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.999999999988271	-1.172895203583e-11	33	0	0	211	8202
R-HSA-72187	mRNA 3'-end processing	0.999999999988271	-1.172895203583e-11	33	0	0	211	8202
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-390648	Muscarinic acetylcholine receptors	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-75157	FasL/ CD95L signaling	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-5652084	Fructose metabolism	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-2161541	Abacavir metabolism	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-3000471	Scavenging by Class B Receptors	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-167827	The proton buffering model	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-1300652	Sperm:Oocyte Membrane Binding	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-444209	Free fatty acid receptors	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-1614517	Sulfide oxidation to sulfate	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-197264	Nicotinamide salvaging	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-114516	Disinhibition of SNARE formation	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-390651	Dopamine receptors	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-71032	Propionyl-CoA catabolism	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-187024	NGF-independant TRKA activation	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-380095	Tachykinin receptors bind tachykinins	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-157881	Cyclin B2 mediated events	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-111463	SMAC binds to IAPs	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-112303	Electric Transmission Across Gap Junctions	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-561048	Organic anion transport	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-391906	Leukotriene receptors	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-68911	G2 Phase	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-426048	Arachidonate production from DAG	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-1169092	Activation of RAS in B cells	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-112307	Transmission across Electrical Synapses	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-167826	The fatty acid cycling model	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-209931	Serotonin and melatonin biosynthesis	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-111469	SMAC-mediated apoptotic response	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.99999999998867	-1.13300352797331e-11	5	0	0	211	8202
R-HSA-5334118	DNA methylation	0.99999999998945	-1.05497722411524e-11	62	0	0	211	8202
R-HSA-1222499	Response of Mtb to phagocytosis	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-5602410	TLR3 deficiency - HSE	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-389542	NADPH regeneration	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-1839128	FGFR4 mutant receptor activation	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-163316	Mitochondrial transcription termination	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-2534343	Interaction With Cumulus Cells	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-3248023	Regulation by TREX1	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-169131	Inhibition of PKR	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-162589	Reverse Transcription of HIV RNA	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-1483076	Synthesis of CL	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-171286	Synthesis and processing of ENV and VPU	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-140180	COX reactions	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-162585	Uncoating of the HIV Virion	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-164525	Plus-strand DNA synthesis	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-164516	Minus-strand DNA synthesis	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-1222449	Mtb iron assimilation by chelation	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-1300645	Acrosome Reaction	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-5619084	ABC transporter disorders	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-5602415	UNC93B1 deficiency - HSE	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-2033515	t(4;14) translocations of FGFR3	0.999999999989465	-1.05353920032414e-11	1	0	0	211	8202
R-HSA-73864	RNA Polymerase I Transcription	0.999999999990018	-9.98180373470061e-12	109	0	0	211	8202
R-HSA-212165	Epigenetic regulation of gene expression	0.999999999990058	-9.94199160778787e-12	124	0	0	211	8202
R-HSA-111996	Ca-dependent events	0.999999999990776	-9.22350745118339e-12	30	0	0	211	8202
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	0.999999999990776	-9.22350745118339e-12	30	0	0	211	8202
R-HSA-157858	Gap junction trafficking and regulation	0.999999999990776	-9.22350745118339e-12	30	0	0	211	8202
R-HSA-174824	Lipoprotein metabolism	0.999999999990776	-9.22350745118339e-12	30	0	0	211	8202
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.999999999990776	-9.22350745118339e-12	30	0	0	211	8202
R-HSA-72086	mRNA Capping	0.999999999990776	-9.22350745118339e-12	30	0	0	211	8202
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	0.999999999990776	-9.22350745118339e-12	30	0	0	211	8202
R-HSA-420029	Tight junction interactions	0.999999999990776	-9.22350745118339e-12	30	0	0	211	8202
R-HSA-73762	RNA Polymerase I Transcription Initiation	0.999999999990915	-9.0852715116161e-12	48	0	0	211	8202
R-HSA-3214842	HDMs demethylate histones	0.999999999990915	-9.0852715116161e-12	48	0	0	211	8202
R-HSA-390466	Chaperonin-mediated protein folding	0.999999999991193	-8.80674332301697e-12	49	0	0	211	8202
R-HSA-936837	Ion transport by P-type ATPases	0.999999999991193	-8.80674332301697e-12	49	0	0	211	8202
R-HSA-171306	Packaging Of Telomere Ends	0.999999999991193	-8.80674332301697e-12	49	0	0	211	8202
R-HSA-162599	Late Phase of HIV Life Cycle	0.999999999991849	-8.15083480470046e-12	127	0	0	211	8202
R-HSA-432720	Lysosome Vesicle Biogenesis	0.999999999992547	-7.45301568836157e-12	35	0	0	211	8202
R-HSA-76046	RNA Polymerase III Transcription Initiation	0.999999999992547	-7.45301568836157e-12	35	0	0	211	8202
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	0.999999999992547	-7.45301568836157e-12	35	0	0	211	8202
R-HSA-1251985	Nuclear signaling by ERBB4	0.999999999992688	-7.31216513823563e-12	40	0	0	211	8202
R-HSA-5675221	Negative regulation of MAPK pathway	0.999999999992688	-7.31216513823563e-12	40	0	0	211	8202
R-HSA-1474165	Reproduction	0.999999999992781	-7.21881547717309e-12	26	0	0	211	8202
R-HSA-264876	Insulin processing	0.999999999992781	-7.21881547717309e-12	26	0	0	211	8202
R-HSA-983189	Kinesins	0.999999999992781	-7.21881547717309e-12	26	0	0	211	8202
R-HSA-975298	Ligand-gated ion channel transport	0.999999999992781	-7.21881547717309e-12	26	0	0	211	8202
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.999999999992781	-7.21881547717309e-12	26	0	0	211	8202
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	0.999999999992781	-7.21881547717309e-12	26	0	0	211	8202
R-HSA-1187000	Fertilization	0.999999999992781	-7.21881547717309e-12	26	0	0	211	8202
R-HSA-5663220	RHO GTPases Activate Formins	0.999999999992858	-7.14201515296028e-12	114	0	0	211	8202
R-HSA-113418	Formation of the Early Elongation Complex	0.999999999993107	-6.8933376652802e-12	34	0	0	211	8202
R-HSA-1489509	DAG and IP3 signaling	0.999999999993107	-6.8933376652802e-12	34	0	0	211	8202
R-HSA-177243	Interactions of Rev with host cellular proteins	0.999999999993107	-6.8933376652802e-12	34	0	0	211	8202
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.999999999993107	-6.8933376652802e-12	34	0	0	211	8202
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.999999999993107	-6.8933376652802e-12	34	0	0	211	8202
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.999999999993288	-6.71224092483384e-12	63	0	0	211	8202
R-HSA-380284	Loss of proteins required for interphase microtubule organizationfrom the centrosome	0.999999999993288	-6.71224092483384e-12	63	0	0	211	8202
R-HSA-5673000	RAF activation	0.999999999993699	-6.30069999552822e-12	25	0	0	211	8202
R-HSA-5669034	TNFs bind their physiological receptors	0.999999999993699	-6.30069999552822e-12	25	0	0	211	8202
R-HSA-977068	Termination of O-glycan biosynthesis	0.999999999993699	-6.30069999552822e-12	25	0	0	211	8202
R-HSA-162588	Budding and maturation of HIV virion	0.999999999993699	-6.30069999552822e-12	25	0	0	211	8202
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.999999999993699	-6.30069999552822e-12	25	0	0	211	8202
R-HSA-380994	ATF4 activates genes	0.999999999993699	-6.30069999552822e-12	25	0	0	211	8202
R-HSA-3295583	TRP channels	0.999999999993699	-6.30069999552822e-12	25	0	0	211	8202
R-HSA-1461973	Defensins	0.999999999993885	-6.11543231056857e-12	51	0	0	211	8202
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.999999999993885	-6.11543231056857e-12	51	0	0	211	8202
R-HSA-1502540	Signaling by Activin	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-1679131	Trafficking and processing of endosomal TLR	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-209560	NF-kB is activated and signals survival	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-211227	Activation of DNA fragmentation factor	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-2029481	FCGR activation	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-350054	Notch-HLH transcription pathway	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-174403	Glutathione synthesis and recycling	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-977441	GABA A receptor activation	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-5210891	Uptake and function of anthrax toxins	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-171007	p38MAPK events	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-74217	Purine salvage	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-209543	p75NTR recruits signalling complexes	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-140342	Apoptosis induced DNA fragmentation	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-209822	Glycoprotein hormones	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-75892	Platelet Adhesion to exposed collagen	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-175474	Assembly Of The HIV Virion	0.999999999994202	-5.79834399045099e-12	13	0	0	211	8202
R-HSA-5578749	Transcriptional regulation by small RNAs	0.999999999994742	-5.2584822224348e-12	101	0	0	211	8202
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	0.999999999995188	-4.81241266690366e-12	28	0	0	211	8202
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	0.999999999995188	-4.81241266690366e-12	28	0	0	211	8202
R-HSA-5218920	VEGFR2 mediated vascular permeability	0.999999999995188	-4.81241266690366e-12	28	0	0	211	8202
R-HSA-190828	Gap junction trafficking	0.999999999995188	-4.81241266690366e-12	28	0	0	211	8202
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	0.999999999995188	-4.81241266690366e-12	28	0	0	211	8202
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.999999999995188	-4.81241266690366e-12	28	0	0	211	8202
R-HSA-111933	Calmodulin induced events	0.999999999995188	-4.81241266690366e-12	28	0	0	211	8202
R-HSA-381042	PERK regulates gene expression	0.999999999995188	-4.81241266690366e-12	28	0	0	211	8202
R-HSA-111997	CaM pathway	0.999999999995188	-4.81241266690366e-12	28	0	0	211	8202
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE	0.999999999995188	-4.81241266690366e-12	28	0	0	211	8202
R-HSA-112040	G-protein mediated events	0.999999999995302	-4.6982724883405e-12	47	0	0	211	8202
R-HSA-3214815	HDACs deacetylate histones	0.999999999995799	-4.20105361608327e-12	94	0	0	211	8202
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.999999999996379	-3.62101764065268e-12	46	0	0	211	8202
R-HSA-73776	RNA Polymerase II Promoter Escape	0.999999999996379	-3.62101764065268e-12	46	0	0	211	8202
R-HSA-112043	PLC beta mediated events	0.999999999996379	-3.62101764065268e-12	46	0	0	211	8202
R-HSA-167161	HIV Transcription Initiation	0.999999999996379	-3.62101764065268e-12	46	0	0	211	8202
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.999999999996379	-3.62101764065268e-12	46	0	0	211	8202
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.999999999996379	-3.62101764065268e-12	46	0	0	211	8202
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.999999999996379	-3.62101764065268e-12	46	0	0	211	8202
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.999999999996806	-3.19357825469245e-12	107	0	0	211	8202
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.999999999996806	-3.19357825469245e-12	107	0	0	211	8202
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.999999999996982	-3.01758126717018e-12	70	0	0	211	8202
R-HSA-212300	PRC2 methylates histones and DNA	0.999999999996982	-3.01758126717018e-12	70	0	0	211	8202
R-HSA-774815	Nucleosome assembly	0.999999999996982	-3.01758126717018e-12	70	0	0	211	8202
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.999999999997248	-2.75176150385712e-12	43	0	0	211	8202
R-HSA-1296072	Voltage gated Potassium channels	0.999999999997248	-2.75176150385712e-12	43	0	0	211	8202
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.999999999997248	-2.75176150385712e-12	43	0	0	211	8202
R-HSA-167169	HIV Transcription Elongation	0.999999999997248	-2.75176150385712e-12	43	0	0	211	8202
R-HSA-3214841	PKMTs methylate histone lysines	0.999999999997522	-2.47804317678785e-12	64	0	0	211	8202
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.999999999997522	-2.47804317678785e-12	64	0	0	211	8202
R-HSA-166658	Complement cascade	0.999999999997944	-2.0562848363857e-12	38	0	0	211	8202
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	0.999999999998135	-1.86486605158776e-12	65	0	0	211	8202
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.999999999998135	-1.86486605158776e-12	65	0	0	211	8202
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	0.999999999998279	-1.72082448160927e-12	54	0	0	211	8202
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.999999999998279	-1.72082448160927e-12	54	0	0	211	8202
R-HSA-1475029	Reversible hydration of carbon dioxide	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-156581	Methylation	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-203615	eNOS activation	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-2022857	Keratan sulfate degradation	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-451306	Ionotropic activity of Kainate Receptors	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-390666	Serotonin receptors	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-71384	Ethanol oxidation	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-2168880	Scavenging of heme from plasma	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-211958	Miscellaneous substrates	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-1296346	Tandem pore domain potassium channels	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-176974	Unwinding of DNA	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-417957	P2Y receptors	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-202670	ERKs are inactivated	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-166786	Creation of C4 and C2 activators	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-844456	The NLRP3 inflammasome	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-381033	ATF6-alpha activates chaperones	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-389359	CD28 dependent Vav1 pathway	0.999999999999038	-9.61524107088525e-13	12	0	0	211	8202
R-HSA-211000	Gene Silencing by RNA	0.999999999999215	-7.85536347936519e-13	130	0	0	211	8202
R-HSA-3214858	RMTs methylate histone arginines	0.999999999999326	-6.74033202535165e-13	75	0	0	211	8202
R-HSA-73777	RNA Polymerase I Chain Elongation	1.00000000000064	6.3832762877989e-13	88	0	0	211	8202
R-HSA-73728	RNA Polymerase I Promoter Opening	1.0000000000011	1.10023366905897e-12	60	0	0	211	8202
R-HSA-73923	Lipid digestion, mobilization, and transport	1.0000000000011	1.10023366905897e-12	60	0	0	211	8202
R-HSA-111931	PKA-mediated phosphorylation of CREB	1.00000000000131	1.30747049690167e-12	17	0	0	211	8202
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1.00000000000131	1.30747049690167e-12	17	0	0	211	8202
R-HSA-622312	Inflammasomes	1.00000000000131	1.30747049690167e-12	17	0	0	211	8202
R-HSA-435354	Zinc transporters	1.00000000000131	1.30747049690167e-12	17	0	0	211	8202
R-HSA-196299	Beta-catenin phosphorylation cascade	1.00000000000131	1.30747049690167e-12	17	0	0	211	8202
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	1.00000000000131	1.30747049690167e-12	17	0	0	211	8202
R-HSA-69205	G1/S-Specific Transcription	1.00000000000131	1.30747049690167e-12	17	0	0	211	8202
R-HSA-1482925	Acyl chain remodelling of PG	1.00000000000131	1.30747049690167e-12	17	0	0	211	8202
R-HSA-164378	PKA activation in glucagon signalling	1.00000000000131	1.30747049690167e-12	17	0	0	211	8202
R-HSA-174800	Chylomicron-mediated lipid transport	1.00000000000131	1.30747049690167e-12	17	0	0	211	8202
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	1.00000000000131	1.30747049690167e-12	17	0	0	211	8202
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	1.00000000000131	1.30747049690167e-12	17	0	0	211	8202
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	1.00000000000131	1.30747049690167e-12	17	0	0	211	8202
R-HSA-432142	Platelet sensitization by LDL	1.00000000000131	1.30747049690167e-12	17	0	0	211	8202
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	1.00000000000133	1.33054883782521e-12	29	0	0	211	8202
R-HSA-375170	CDO in myogenesis	1.00000000000133	1.33054883782521e-12	29	0	0	211	8202
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	1.00000000000133	1.33054883782521e-12	29	0	0	211	8202
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	1.00000000000133	1.33054883782521e-12	29	0	0	211	8202
R-HSA-5339562	Uptake and actions of bacterial toxins	1.00000000000133	1.33054883782521e-12	29	0	0	211	8202
R-HSA-445095	Interaction between L1 and Ankyrins	1.00000000000133	1.33054883782521e-12	29	0	0	211	8202
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	1.00000000000133	1.33054883782521e-12	29	0	0	211	8202
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	1.00000000000133	1.33054883782521e-12	29	0	0	211	8202
R-HSA-525793	Myogenesis	1.00000000000133	1.33054883782521e-12	29	0	0	211	8202
R-HSA-391251	Protein folding	1.00000000000164	1.64376698605123e-12	55	0	0	211	8202
R-HSA-380108	Chemokine receptors bind chemokines	1.00000000000265	2.65155721498466e-12	56	0	0	211	8202
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-174577	Activation of C3 and C5	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-3323169	Defects in biotin (Btn) metabolism	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-3656225	Defective CHST6 causes MCDC1	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-199920	CREB phosphorylation	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-447038	NrCAM interactions	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-75158	TRAIL  signaling	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-162791	Attachment of GPI anchor to uPAR	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-426117	Cation-coupled Chloride cotransporters	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-166665	Terminal pathway of complement	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-429593	Inositol transporters	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-74182	Ketone body metabolism	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-5619102	SLC transporter disorders	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-5603029	IkBA variant leads to EDA-ID	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-448706	Interleukin-1 processing	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-2214320	Anchoring fibril formation	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-164843	2-LTR circle formation	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-426496	Post-transcriptional silencing by small RNAs	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-2142789	Ubiquinol biosynthesis	1.00000000000319	3.18609579255922e-12	7	0	0	211	8202
R-HSA-427413	NoRC negatively regulates rRNA expression	1.00000000000358	3.58105629245799e-12	104	0	0	211	8202
R-HSA-381753	Olfactory Signaling Pathway	1.00000000000466	4.66172515954463e-12	381	0	0	211	8202
R-HSA-167172	Transcription of the HIV genome	1.00000000000491	4.91098059577464e-12	67	0	0	211	8202
R-HSA-1632852	Macroautophagy	1.00000000000491	4.91098059577464e-12	67	0	0	211	8202
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	1.00000000000514	5.13958249416878e-12	39	0	0	211	8202
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	1.00000000000514	5.13958249416878e-12	39	0	0	211	8202
R-HSA-6782315	tRNA modification in the nucleus and cytosol	1.00000000000514	5.13958249416878e-12	39	0	0	211	8202
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	1.00000000000514	5.13958249416878e-12	39	0	0	211	8202
R-HSA-162587	HIV Life Cycle	1.0000000000061	6.10374763908387e-12	140	0	0	211	8202
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	1.00000000001065	1.06454946789135e-11	50	0	0	211	8202
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	1.00000000001459	1.45929184247043e-11	21	0	0	211	8202
R-HSA-211981	Xenobiotics	1.00000000001459	1.45929184247043e-11	21	0	0	211	8202
R-HSA-2024096	HS-GAG degradation	1.00000000001459	1.45929184247043e-11	21	0	0	211	8202
R-HSA-379726	Mitochondrial tRNA aminoacylation	1.00000000001459	1.45929184247043e-11	21	0	0	211	8202
R-HSA-5621575	CD209 (DC-SIGN) signaling	1.00000000001459	1.45929184247043e-11	21	0	0	211	8202
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	1.00000000001459	1.45929184247043e-11	21	0	0	211	8202
R-HSA-198753	ERK/MAPK targets	1.00000000001459	1.45929184247043e-11	21	0	0	211	8202
R-HSA-156588	Glucuronidation	1.00000000001459	1.45929184247043e-11	21	0	0	211	8202
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	1.00000000001459	1.45929184247043e-11	21	0	0	211	8202
R-HSA-5620916	VxPx cargo-targeting to cilium	1.00000000001459	1.45929184247043e-11	21	0	0	211	8202
